What changed in this filing

/stocks — the workspaceLOADING

Item 9A. Controls and Procedures

2025-03-28 compared with 2024-04-10 · 690 added, 1737 removed, 76 unchanged (97% of the section changed)

1 unchanged sentence

Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer (who is our principal executive officer)

and Chief Financial Officer (who is our principal financial officer), conducted an evaluation of the effectiveness of the design and operation

of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange

Act of 1934 (the “Exchange Act”) as of December 31, 2023.

As of December 31, 2023, based upon the evaluation, our principal

executive officer and principal financial officer concluded that our disclosure controls and procedures were effective.

Disclosure controls

and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act,

such as this report, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

Management’s Report on Internal Controls

Over Financial Reporting

As required by SEC rules and regulations implementing Section 404

of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over financial reporting.

Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting

and the preparation of our financial statements for external reporting purposes in accordance with GAAP.

Our internal control over financial

reporting includes those policies and procedures that:

to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets

of our company,

reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP,

and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and

reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could

have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial

reporting may not prevent or detect errors or misstatements in our financial statements.

Also, projections of any evaluation of effectiveness

to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or

compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of our internal control over financial

reporting at December 31, 2023.

In making these assessments, management used the criteria set forth by the Committee of Sponsoring

Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework (2013).

Based on our assessments and

those criteria, management determined that our internal controls over financial reporting were effective as of December 31, 2023.

This Report does not include an attestation report of our independent

registered public accounting firm due to our status as an emerging growth company and a smaller reporting company.

Management is responsible for establishing and maintaining adequate internal control over our financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting.

Management has used the framework set forth in the report entitled “Internal Control—Integrated Framework (2013)” published by the Committee of Sponsoring Organizations of the Treadway Commission to evaluate the effectiveness of our internal control over financial reporting.

Based on that assessment, our management has identified certain material weaknesses in our internal control over financial reporting.

Prior to the Merger, we were a private company and had limited accounting and financial reporting personnel with which to address our internal controls and related procedures.

Our management concluded that as of December 31, 2024, our internal control over financial reporting was not effective, and that material weaknesses existed in the areas of accounting for complex financial transactions or non-routine transactions.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting as defined under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and by the Public Company Accounting Oversight Board (United States), such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

We currently consult with third-party experts to overcome this weakness.

Additionally, we had a material weakness related to segregation of duties in finance and accounting.

Due to our limited accounting and financial reporting personnel, we have ineffective controls over the period end financial disclosure and reporting process.

We are in the process of implementing measures designed to improve our internal control over financial reporting to remediate the material weaknesses and have plans to implement them in the first half of 2025.

For example, we plan to design and implement improved processes and internal controls, including ongoing senior management review and Audit Committee oversight.

Additionally, we plan to further develop and implement formal policies, processes and documentation procedures relating to our financial reporting, including the oversight of third-party service providers.

Our actions are subject to ongoing executive management review and will also be subject to Audit Committee oversight.

Notwithstanding the material weaknesses in internal control over financial reporting described above, our management has concluded that our consolidated financial statements included in this Annual Report on Form 10-K are fairly stated in all material respects.

Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over our financial reporting.

This Annual Report on Form 10-K does not include a report of management’s assessment regarding internal control over financial reporting, as allowed by the SEC for reverse recapitalization between an issuer and a private operating company when it is not possible to conduct an assessment of the private operating company’s internal control over financial reporting in the period between the consummation date of the reverse recapitalization and the date of management’s assessment of internal control over financial reporting (pursuant to Section 215.02 of the SEC Division of Corporation Finance’s Regulation S-K Compliance & Disclosure Interpretations).

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting

that occurred during the fiscal quarter ended December 31, 2023, that have materially affected, or are reasonably likely to materially

affect, our internal control over financial reporting.

There were no changes in our internal control over financial reporting that occurred during our most recent fiscal year that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Other Information

DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not applicable.

1 unchanged sentence

Executive Officers and Directors

The following table provides information regarding our key employees

and directors:

Executive Officers

President, Chief Executive Officer and Chairman

Frances Scally

Chief Financial Officer and Secretary

Non-Employee Directors

Douglas Miscoll

David Pfeffer

Executive Officers

Daniel Jones is our Chief Executive Officer and Chairman

of the Board.

He has been our co-founder, President, and a member of our board of directors since our inception.

He has served as Chief

Executive Officer since May 2018 and was elected Chairman of the Board in March 2021.

Prior to becoming our CEO, he was President

from inception to May 2018.

Jones has over 15 years of biotechnology industry experience, including 12 plus years

in single molecule sequencing research.

Prior to founding our company, Mr.

Jones held various positions at Helicos Biosciences, a

publicly-traded biotechnology tools company.

During his career at Helicos Biosciences, his responsibilities included applications development,

instrument prototyping and validation, customer support and bioinformatics analysis, as well as sales and operations.

ran the first ever direct RNA sequencing experiments while at Helicos.

From December 2003 to March 2007, Mr.

Genomics in the Methods Development group and on development of its Trilogy 2020 Single Molecule Analyzer and Direct miRNA

From December 2002 to December 2003, Mr.

Jones worked at EXACT Sciences on its ColoGuard assay, a non-invasive,

now FDA-approved molecular diagnostic for colorectal cancer.

Jones has authored or co-authored four publications and is named

on multiple patents or patent applications.

He holds a B.S.

degree from Trinity College and has studied biotechnology and bioinformatics

at Brandeis University and the University of Massachusetts.

The following table sets forth the name and position of each person who is an executive officer or director of the Company.

Name Age Position

Prateek Gattani 46 Chairman of the Board

Machinist 72 Vice Chairman of the Board

Jeffrey Jagid 56 Chief Executive Officer and Director

Christopher Broderick 64 Chief Operating Officer and Chief Financial Officer

Michael Tenore 50 General Counsel and Secretary

Jeff Kurtz 56 Director

David Solimine 45 Director

David Pfeffer 65 Director

Prateek Gattani serves as our Chairman of the Board and has been Chief Executive Officer of IDC since 2007.

Gattani acquired IDC in 2007, which, in turn, acquired Lyneer in August 2021.

Prior to 2007, Mr.

Gattani was a resource manager at e-Solutions Incorporated.

IDC, founded in India in 2003, is a major information technology company.

IDC currently provides business process outsourcing, IT consulting, revenue sources and software as a service (SaaS).

According to Forbes India (August 2022) , IDC ranks in the 95 th percentile market share and had three-year growth of 488% from 2020 to 2022.

IDC is headquartered in Milpitas, California and has offices throughout the world.

IDC is a multinational technology company that provides the highest level of knowledge and experience to assist its customers to redesign and recreate their ventures in order to stay in the competition in the changing business environment.

IDC’s ability to know the business and personal environment of its clients helps them to provide tailored services according to the areas of operation, in the fields of innovation, as well as in culture.

We believe Mr.

Jones’ experience in the pharmaceutical industry

as well as his extensive understanding of our business, operations and strategy qualifies him to serve on our board of directors.

Frances Scally has served as our Chief Financial Officer

and Secretary since August 2022.

Scally has over 30 years’ experience in strategic accounting and financial leadership,

including serving as chief financial officer, chief accounting officer and in other senior financial executive roles at both domestic

and multi-national public and private companies.

Since October 2021, Ms.

Scally has been a Managing Director at DLA LLC, an Advisory

firm, in which capacity she provides accounting advisory services.

Prior to joining DLA LLC, Ms.

Scally was the Chief Accounting Officer

and Acting Chief Financial Officer of Aceto Holdings, L.P.

from April 2019 to April 2020, as well as the Chief Accounting Officer

of Aceto Corporation from March 2007 to April 2019.

Aceto Corporation is an international company engaged in the development,

marketing, sale and distribution of human health products, pharmaceutical ingredients and performance chemicals.

Prior to joining Aceto,

Scally was the Director of Financial Reporting and Compliance at Veeco Instruments Inc., a manufacturer of semiconductor process equipment,

from 1998-2007.

From 1989-1998, Ms.

Scally was employed by Ernst & Young LLP.

Scally received a bachelor’s

degree in accounting from LIU Post and is a Certified Public Accountant.

She is a member of New York State Society of CPAs and American

Institute of Certified Public Accountants.

Scally also is a Trustee and a member of the Finance Committee for St.

Edward the Confessor

Church and School.

Scally’s services as our Chief Financial Officer are being

secured pursuant to the terms of our Master Services Agreement with DLA LLC, where Ms.

Scally is an employee.

Non-Employee Directors

has served as a member of

our board of directors since August 2021.

Since September 2020, Dr.

Milos has been Vice President, Scientific Operations

of Proof Diagnostics, Inc., a company that is developing a low-cost, rapid diagnostic, point-of-care testing platform for the detection

From October 2016 to September 2020, Dr.

Milos was a co-founder, President and Chief Executive Officer of

Medley-Genomics Inc., a company focused on using advanced data analytics to support better diagnosis and treatment of complex diseases.

From May 2013 to January 2016, Dr.

Milos was President and Chief Executive Officer of Claritas Genomics Inc., a subsidiary

of Boston Children’s Hospital that provided commercial next-generation pediatric molecular diagnostic testing.

Additional experience

included executive roles at Helicos BioSciences and Pfizer, Inc.

Milos is also a member of the board of directors of 54Gene Inc.,

and Nigeria-based startup that collects African genetic code for use in health research and drug development, Slater

Technology Fund, a seed-stage venture investor in early-stage technology ventures, ProThera Biologics, a life-sciences company

developing a fundamentally new paradigm for treating severe inflammation and RI Bio, a bioscience, biotech, health and life sciences industry

network group dedicated to galvanizing collaboration among industry participants.

Milos has received numerous awards and honors

within the life sciences industry and has authored or co-authored over 60 biotech or life sciences publications.

She earned a B.A.

in biology and chemistry from The College of Saint Rose, a M.S.

in plant molecular genetics and biology from Rensselaer Polytechnic

Institute and has completed Post-Doctoral work at Harvard University and Brown University in plant and mouse molecular genetics.

We believe Dr.

Milos’ management experience and her extensive

background and experience in molecular genetics and biology qualifies her to serve on our board of directors.

Douglas Miscoll has served as a member of our board of

directors since October 2015.

Miscoll founded Ravello Precision Partners in 2015, which operated as a hedge fund focused

on genomic biology companies.

Miscoll founded Ravello Partners LLC in 2010, which manages discretionary portfolios for families

and small institutions and is active in the biotechnology sector.

From 1999 until 2009, Mr.

Miscoll was a Managing Director at Newlight

Management, where he was responsible for managing all aspects of two private equity funds and a hedgefund focused on technology, media

and communications companies.

He originated and directed the firm’s public market investment activities.

Previously, from 1994 to

1995, he was a Managing Director of Northgate Ventures, a venture capital fund focused on early stage technology companies.

was a founding member of the management team that created K-III Communications, a leveraged build-up in the publishing and information

services industries sponsored by Kohlberg Kravis Roberts & Co.

Miscoll received an M.B.A.

from Georgetown University,

a Graduate Certificate from Templeton College, Oxford University, and a B.A.

from Santa Clara University.

Gattani’s business and financial experience in the staffing business, and his vision for future operations, gives him the qualifications and skills to lead us as Chairman of the Board.

Machinis t serves as our Vice Chairman of the Board.

He has served as Chairman of the Board of Atlantic since its formation in October 2022.

He previously served as Chief Executive Officer and Chairman of the Board of Troika Media Group (Nasdaq:

TRKA) from March 2018 until May 2022.

Machinist has extensive experience both as a principal investor/operator in a broad range of businesses as well as an owner-operator of diversified investment banking operations.

He has been the Vice Chairman of Pyrolyx A.G.

(S26.DU), the first environmentally-friendly and sustainable method of recovering high-grade carbon black from end-of-life-tires.

Most recently, he has been Chairman and an original founding Board member of CIFC Corp.

CIFC), a publicly-listed credit manager with over $14.0 billion of assets under management, which was sold in December 2016.

In addition, he has been Chairman, Board of Advisors of MESA, a merchant bank specializing in media and entertainment industry transactions, which was sold to Houlihan Lokey in 2016.

He has also been a partner of Columbus Nova, a leading private investment fund.

He runs a private family investment company, the activities of which include The Collectors Car Garage and a number of real estate development businesses.

Machinist previously served as managing director and head of investment banking for the Bank of New York and its Capital Markets division.

Machinist was also previously president and one of the principal founders of Patricof & Co.

Capital Corp.

(APAX Purchasers) and its successor companies.

He is currently Vice-Chairman of the Maimonides Medical Center, serves on its Board of Directors, is Chairman of its Investment Committee and a member of its various other Board of Overseers for the Albert Einstein College of Medicine.

Most recently, he has been Chairman of the American Committee for the Weizmann Institute of Science as well as a member of its Board of Directors and presently serves on its International Board of Governors and its Executive Committee.

He has been a trustee and Vice Chairman of Vassar College, a member of its Executive Committee, and one of three trustees responsible for managing the College’s Endowment.

He is currently a board member of ECD Autodesign (Nasdaq:

Machinist earned a Bachelor of Arts in Philosophy and Chemistry from Vassar College in Poughkeepsie, New York.

He undertook graduate work in biochemistry at the Weizmann Institute of Science in Rehovot, Israel.

Machinist’s broad entrepreneurial, financial and business expertise and his experience with growth companies give him significant qualifications and skills to serve as Vice Chairman of our board of directors.

Jeffrey Jagid serves as our Chief Executive Officer and a Director.

He has served as CEO of Atlantic since February 1, 2023.

He is a results-producing business executive with a strong track record of optimizing revenue and profitability within a global organization.

He has demonstrated success building and leading businesses at all stages of growth.

Prior to joining Atlantic, Mr.

Jagid was a director of ThinkEco Inc.

since 2014 and became that company’s Chairman and Chief Executive Officer in 2017.

Prior to joining ThinkEco, Mr.

Jagid held various management positions at I.D.

Systems, Inc.

IDSY), including Chief Executive Officer and Chairman of the Board of Directors.

Jagid’s leadership, I.D.

Systems was named by Deloitte as one of North America’s fastest growing technology companies in 2005, 2006 and 2012.

During his tenure at I.D.

Jagid was named as a finalist for the Deloitte Entrepreneur of the Year award.

Jagid’s leadership, I.D.

Systems became a leading global provider of wireless IoT based technology solutions for securing, managing, and tracking high-value enterprise assets.

He has been awarded 14 patents in wireless communications, mobile data, asset tracking, and connected car technology.

Among his other achievements, he led that company’s initial public offering, as well as several other capital raises totaling nearly $100,000,000.

From 2001 to June 2014, Mr.

Jagid also served on the board of directors of Coining Technologies, Inc., a privately-held company in the coining, forming, drawing, and piercing of specialty metals, mass-producing close-tolerance complex parts quickly and cost-effectively.

Jagid received a Bachelor of Business Administration from Emory University in 1991 and a Juris Doctor degree from the Benjamin N.

Cardozo School of Law in 1994.

He is member of the Bar of the States of New York and New Jersey.

Christopher Broderick serves as our Chief Financial Officer.

He had served as Chief Operating Officer and Chief Financial Officer of Atlantic since February 1, 2023.

From July 2017 until June 8, 2022, he served as Chief Operating Officer of Troika Media Group (“Troika”).

On December 7, 2023, Troika and certain of its subsidiaries filed voluntary petitions under Chapter 11 of the United States Code in the U.S.

Bankruptcy Court for the Southern District of New York.

From March 27, 2015 until October 2016, he was Chief Operating Officer and Interim Chief Financial Officer.

Prior thereto, he had served as Chief Operating Officer of Signal Point Holdings Corp.

(SPHC) from October 17, 2012.

Broderick has 30 years of experience in the telecommunications industry and was responsible for that company’s domestic network operations of wired and wireless topologies, supporting voice, data, internet products and services.

He was also the operational leader for the development and build-out of SPHC’s continued network expansion.

Prior to joining SPHC, Mr.

Broderick served as Senior Director of Business Client Services for FairPoint Communications from 2008 to 2011.

Broderick was responsible for Retail Business segment, outside sales support, billing, and SMB sales across Northern New England.

Previously, Mr.

Broderick served as Chief Operating Officer and Vice President of Operations at IntelliSpace and Wave2Wave from February 2000 to January 2008.

Broderick was responsible for the design, implementation and day-to-day U.S.

operations of that company.

Broderick spent the majority of his career at New York Telephone, NYNEX, and Bell Atlantic where he was highly successful in the management of all facets of the telephone company’s Field Operations, Central Offices and outside plant facilities in New York City business districts.

He also led sales and support “mega” call-center operations, for complex business accounts.

In addition to his technical background, Mr.

Broderick has an extensive education in quality process management, systems efficiency and design.

He has utilized his extensive background to help build SPHC into one of the most reliable “Converged Networks” in the USA.

Atlantic determined that Mr.

Broderick’s 30 years of particular knowledge and experience in the telecommunications industry, and his position with SPHC, strengthens the Board’s collective qualifications, skills and experience.

Michael Tenore serves as our General Counsel and Secretary.

He has served as General Counsel of Atlantic since March 2023.

He was first appointed General Counsel, and Vice President of Regulatory Affairs for Troika in March 2015.

In July 2017, Mr.

Tenore was elected Corporate Secretary.

He served in those positions until March 31, 2023.

On December 7, 2023, Troika and certain of its subsidiaries filed voluntary petitions under Chapter 11 of the United States Code in the U.S.

Bankruptcy Court for the Southern District of New York.

Prior to joining Troika in March 2015 upon the merger with Signal Point Holdings Corp., he held various legal and regulatory positions, including General Counsel, at RNK, Inc.

a regional telecommunications carrier.

Tenore is a member of the adjunct staff of Suffolk University Law School and belongs to the Federal Communications Bar Association and the Association of Corporate Counsel.

Tenore received his B.A.

in Communications from Emerson College and his J.D.

from Suffolk University Law School both

degrees with Latin Honors.

Tenore has been on the board of directors for youth hockey and charitable organizations for the past 10 years.

Jeff Kurtz was elected to our board of directors upon the consummation of the Merger.

Since 1991, he has been the President of The Kamson Corporation, which currently owns and operates over 100 investment properties in the Northeast.

Currently, he oversees extensive rehabilitation projects among over 100 projects and is presently involved in several building projects consisting of multifamily apartments, hi-rise buildings, and mixed-use properties which have retail and apartment components.

In the past, Mr.

Kurtz has built multifamily units for sale along with other building projects.

Kurtz personally owns or is a general partner and/or manages, through the Kamson Corporation, a New Jersey corporation, 14,000+ apartments, in addition to office buildings and shopping centers.

A graduate of the University of Miami, Mr.

Kurtz is a member of the 1987 National Championship Football Team at the University of Miami.

He continues as an active member of the university alumni.

For the past 20 years, Mr.

Kurtz has been on the Board of the Hope & Heroes Children’s Cancer Fund golf event and chairs this outing each year.

We believe Mr.

Miscoll’s executive management experience

qualifies him to serve on our board of directors.

David Pfeffer has served as a member of our board of

directors since September 2018 and is currently our Audit Committee Chairman.

Pfeffer has over 30 years of experience

in diverse roles in financial services;

leading companies, developing and executing strategy, building businesses up from the ground floor

and driving innovation to grow in today’s ultra-competitive and dynamic global economy.

Pfeffer is currently CEO of

Brick Citi Capital, LLC, an investment services and business advisory firm founded in 2019.

Previously, he was Executive Vice President

and Chief Financial Officer of Oppenheimer Funds, a global asset manager, from 2004 to 2019.

He was a Management Director on the Oppenheimer

Kurtz’s broad entrepreneurial, financial and business expertise and his experience give him the qualifications and skills to serve as a director of our company.

David Solimine was elected to our board of directors upon the consummation of the Merger.

Solimine is the President & Chief Executive Officer of Kore Insurance Holdings, LLC., a privately-owned high-volume insurance agency established in 2012 with offices in New Jersey and Florida.

He plays an integral part in providing a competitive insurance product with the utmost level of professional service to meet client satisfaction in all aspects.

Prior thereto, from 2001-2008, Mr.

Solimine was a principal, as well as the President of Sales and Marketing for EMAR Group, Inc., when it was acquired by Wells Fargo Insurance Services.

Thereafter, while at Wells Fargo, he remained the largest Insurance Sales Producer on the East Coast for many consecutive years.

He also served as Head of Marketing for Princeton Securities from 1999-2001.

Solimine holds a Bachelor of Science in Business/Economics from Brown University.

He is Property and Casualty Insurance Licensed throughout the United States.

We believe Mr.

Solimine’s extensive business and financial experience in the insurance industry, in particular dealing with employment related issues, makes him qualified to serve on our board of directors.

David Pfeffer serves as a member of our board of directors and is currently our Audit Committee Chairman.

Pfeffer was previously a member of the board of directors and the Audit Committee Chairman for SeqLL since September 2018.

Pfeffer has over 30 years of experience in diverse roles in financial services;

leading companies, developing and executing strategy, building businesses up from the ground floor and driving innovation to grow in today’s ultra-competitive and dynamic global economy.

Pfeffer is currently CEO of Brick Citi Capital, LLC, an investment services and business advisory firm founded in 2019.

Previously, he was Executive Vice President and Chief Financial Officer of Oppenheimer Funds, a global asset manager, from 2004 to 2019.

He was a Management Director on the Oppenheimer Funds, Inc.

board and President of Oppenheimer Funds Harbourview Asset Management.

From 2009 to 2019, Mr.

Pfeffer served as an Independent

Director at ICI Mutual Insurance Co., including a role as Audit Committee Chairman.

Pfeffer served as an Independent Director at ICI Mutual Insurance Co., including a role as Audit Committee Chairman.

From 2000 to 2004, Mr.

Pfeffer worked as Institutional

Chief Financial Officer and Director at Citigroup Asset Management.

Pfeffer worked as Institutional Chief Financial Officer and Director at Citigroup Asset Management.

Pfeffer was at J.P.

Morgan from 1984 to 2000, where

he gained significant international experience serving as Chief Financial Officer and Director of JPM Brazil for five years in São

Paulo and supported JPM’s international businesses during his 16 year tenure there.

Pfeffer worked as a public accountant

at Ernst & Whinney from 1981 to 1984.

Pfeffer is a Certified Public Accountant, a Chartered Global Management Accountant

and has his FINRA Series 99 Operations Professional license.

Morgan from 1984 to 2000, where he gained significant international experience serving as Chief Financial Officer and Director of JPM Brazil for five years in São Paulo and supported JPM’s international businesses during his 16-year tenure there.

Pfeffer worked as a public accountant at Ernst & Whinney from 1981 to 1984.

Pfeffer is a Certified Public Accountant, a Chartered Global Management Accountant and has his FINRA Series 99 Operations Professional license.

He graduated Cum Laude from the University of Delaware with a B.S.

in Accounting.

We believe Mr.

Pfeffer’s experience in corporate governance

and capital markets qualifies him to serve on our board of directors.

Family Relationships

There are no family relationships between or among any of our directors

or executive officers.

There are no family relationships among our officers and directors and those of our subsidiaries and affiliated

Board Composition and Classified Board Structure

In accordance with the terms of our restated certificate of incorporation

and amended and restated bylaws, our Board is currently divided into three classes with staggered, three-year terms.

At each annual

meeting of stockholders, the successor to each director whose term then expires will be elected to serve from the time of election and

qualification until the third annual meeting of stockholders following election or such director’s death, resignation or removal,

whichever is earliest to occur.

The current class structure is as follows:

Class I (consisting of Mr.

Jones and Dr.

whose term currently expires at the 2025 Annual Meeting of Stockholders;

Class II (consisting of Mr.

Miscoll), whose term will

expire at the 2023 Annual Meeting of Stockholders;

and Class III (consisting of Mr.

Pfeffer), whose term will expire at the

2024 Annual Meeting of Stockholders.

The primary responsibilities of our board of directors are to provide

oversight, strategic guidance, counseling and direction to our management.

Our board of directors meets on a regular basis.

provide that the authorized number of directors may be changed only by resolution of the board of directors.

We have no formal policy

regarding board diversity.

Our priority in selection of board members is identification of members who will further the interests of our

stockholders through his or her established record of professional accomplishment, the ability to contribute positively to the collaborative

culture among board members, knowledge of our business and understanding of the competitive landscape.

Pfeffer’s experience in corporate governance and capital markets qualifies him to continue to serve on our board of directors following the Merger.

Senior Management

Name Age Position

Todd McNulty 57 Chief Executive Officer of Lyneer Staffing Solutions LLC

James Radvany 65 Chief Financial Officer of Lyneer Staffing Solutions LLC

Todd McNulty serves as Chief Executive Officer of Lyneer Staffing Solutions LLC.

McNulty studied Business Administration and Marketing at York College of Pennsylvania.

After college in 1990, Mr.

McNulty started his career as a Marketing Representative for the Players Club International at Resorts Casino in Atlantic City.

In August 1992, Mr.

McNulty relocated back home to Central NJ and began a 30-year staffing career.

McNulty worked for Staffing

Alternatives, a New Jersey four office family-owned boutique company, focusing on clerical and light industrial staffing.

He led sales from 1992 to September 1997, achieving a record $5,000,000 in new sales his first year.

In October 1997, Mr.

McNulty joined James Radvany with a plan and a mission to become the Delaware Valley’s leading staffing company.

He opened multiple offices and achieved robust growth and profitability within months of office openings.

Throughout the years, Mr.

McNulty assumed the role of Chief Executive Officer with responsibility for its current day-to-day operations and working closely with Lyneer’s Business Development Team in building brand strength and growth throughout the country.

James Radvany serves as Chief Finance Officer of Lyneer Staffing Solutions.

Radvany is a graduate of Susquehanna University.

He started his career as a CPA with Coopers and Lybrand in Philadelphia in 1982 and was promoted to Manager in four years instead of the customary six-year period.

Radvany joined Romac and Associates in 1986 as a Senior Recruiting Manager for accounting and finance professionals.

He was consistently one of the top producers in Lyneer’s Northeast region throughout his seven-year tenure.

Radvany founded his initial staffing company in 1993 and with the addition of Todd McNulty, led Lyneer Staffing Solutions to become one of the top staffing firms in the Delaware Valley in the 1990s.

Lyneer Staffing Solutions started to expand outside of the Delaware Valley in the late 1990s and grew throughout the East Coast and into the Southeast and Midwest sectors of the country.

With the addition of seven West Coast branches in early 2015, Lyneer expanded into a true national staffing company.

In his role as Chief Financial Officer of Lyneer, Mr.

Radvany handles all accounting, acquisitions, financing, legal and insurance issues for Lyneer.

He also works with Mr.

McNulty in running Lyneer’s day-to-day operations.

He has successfully negotiated a $55,000,000 asset-based loan, integrated some smaller acquisitions, set up a very cost-effective workers compensation insurance program and oversees a 12-person accounting and legal department.

Family Relationships between Directors

Directors are elected until their successors are duly elected and qualified.

No family relationship exists between any of the directors and executive officers.

There are no arrangements or understandings with major stockholders, customers, suppliers or others pursuant to which any person referred to above was selected as a director or member of senior management.

To our knowledge, none of the individuals who will serve as a director or executive officer of our company has, during the past 10 years, been involved in any of the legal proceedings listed in Item 401(f) of Regulation S-K.

Director Independence

While our common stock is no longer listed on the Nasdaq Capital

Market, our board of directors has determined that, with respect to our corporate governance, we will continue to comply with the

Nasdaq Marketplace Rules.

The Nasdaq Marketplace Rules require a majority of a listed company’s board of directors to be

comprised of independent directors within one year of listing.

In addition, the Nasdaq Marketplace Rules require that, subject to

specified exceptions, each member of a listed company’s audit, compensation and nominating and corporate governance committees

be independent and that audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the

Exchange Act.

Under Rule 5605(a)(2) of the Nasdaq Marketplace Rules, a

director will only qualify as an “independent director” if, in the opinion of our board of directors, that person does not

have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.

In order to be considered independent for purposes of Rule 10A-3 of the Exchange Act, a member of an audit committee of a listed

company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee,

accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries

or otherwise be an affiliated person of the listed company or any of its subsidiaries.

Our board of directors has reviewed the composition of our board of

directors and its committees and the independence of each director.

Based upon information requested from and provided by each director

concerning his or her background, employment and affiliations, including family relationships, our board of directors has determined that

each of Patrice Milos, Doug Miscoll and David Pfeffer is an “independent director” as defined under Rule 5605(a)(2) of

the Nasdaq Marketplace Rules.

Our board of directors also determined that the directors who serve on our audit committee, our compensation

committee and our nominating and corporate governance committee satisfy the independence standards for such committees established by

the SEC and the Nasdaq Marketplace Rules, as applicable.

In making such determinations, our board of directors considered the relationships

that each such non-employee director has with our company and all other facts and circumstances our board of directors deemed relevant

in determining independence, including the beneficial ownership of our capital stock by each non-employee director.

Board Diversity

In August 2021, the SEC approved a Nasdaq Stock Market proposal to

adopt new listing rules relating to board diversity and disclosure.

As approved by the SEC, the new Nasdaq listing rules require all Nasdaq

listed companies to disclose consistent, transparent diversity statistics regarding their boards of directors.

The Board Diversity Matrix

below presents the Board’s diversity statistics in the format prescribed by the Nasdaq rules.

Board Diversity Matrix (As of March 31, 2024)

Total Number of Directors

Gender Identity

Demographic Background

African American or Black

Alaskan Native or Native American

Hispanic or Latin

Native Hawaiian or Pacific Islander

Two or More Races or Ethnicities

Did Not Disclose Demographic Background

Board Meetings and Committees

During the year ended December 31, 2023, our board of directors held

nine meetings (including regularly scheduled and special meetings), and no director attended fewer than 75% of the total number of meetings

of the board of directors and the committees of which he or she was a member.

In addition, during the year ended December 31, 2023, our

board of directors acted by unanimous written consent on 2 occasions.

Although we do not have a formal policy regarding attendance by members

of our board of directors at annual meetings of stockholders, we encourage, but do not require, directors to attend.

Our board of directors has established three standing committees — audit,

compensation, and nominating and corporate governance — each of which operates under a charter approved by our board of

Copies of each committee’s charter has been posted on the Investor Relations section of our website, which is located

at www.seqll.com .

As we are listed on the Nasdaq Global Select Market, our board of directors has determined that, with respect to our corporate governance, we will comply with the Nasdaq Marketplace Rules.

The Nasdaq Marketplace Rules require a majority of a listed company’s board of directors to be comprised of independent directors within one year of listing.

In addition, the Nasdaq Marketplace Exchange Rules require that, subject to specified exceptions, each member of a listed company’s audit, compensation and nominating and corporate governance committees be independent and that audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act.

Under Rule 5605(a)(2) of the Nasdaq Marketplace Rules, a director will only qualify as an “independent director” if, in the opinion of the issuer’s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.

In order to be considered independent for purposes of Rule 10A-3 of the Exchange Act, a member of an Audit Committee of a listed company may not, other than in his or her capacity as a member of the Audit Committee, the board of directors, or any other board committee, accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries or otherwise be an affiliated person of the listed company or any of its subsidiaries.

Our board of directors has reviewed the composition of the board of directors immediately following consummation of the Merger and its committees and the independence of each director.

Based upon information requested from and provided by each director concerning his or her background, employment and affiliations, including family relationships, our board of directors has determined that each of Prateek Gattani, Jeff Kurtz, David Solimine and David Pfeffer will be an “independent director” as defined under Rule 5605(a)(2).

Our board of directors also determined that the directors who serve on our Audit Committee, our Compensation Committee and our Nominating and Corporate Governance Committee satisfy the independence standards for such committees established by the SEC and the Nasdaq Marketplace Rules, as applicable.

In making such determinations, our board of directors considered the relationships that each such non-employee director has and will have with our company and all other facts and circumstances our board of directors deemed relevant in determining independence, including the beneficial ownership of our capital stock by each non-employee director.

Board Meetings Committees

During the year ended December 31, 2024, our board of directors held 4 meetings (including regularly scheduled and special meetings), and no director attended fewer than 80% of the total number of meetings of the board of directors and the committees of which he was a member.

In addition, during the year ended December 31, 2024, our board of directors acted by unanimous written consent on four occasions.

Although we do not have a formal policy regarding attendance by members of our board of directors at annual meetings of stockholders, we encourage, but do not require, directors to attend.

Our board of directors has established three standing committees — Audit, Compensation, and Nominating and Corporate Governance — each of which operates under a charter approved by our board of directors.

Copies of each committee’s charter are posted on the Investor Relations section of our corporate website, located at www.atlantic-international.com .

Each committee has the composition and responsibilities described below.

Our board of directors may from time

to time establish other committees.

Our board of directors may from time to time establish other committees.

Audit Committee

Our audit committee consists of David Pfeffer, who is the chair of

the committee, Douglas Miscoll and Patrice Milos.

Our board of directors has determined that each of the members of our audit committee

satisfies the Nasdaq Marketplace Rules and SEC independence requirements.

Our Audit Committee consists of David Pfeffer, chair of the committee, Jeff Kurtz and David Solimine.

We have determined that each of our members of the Audit Committee satisfies the Nasdaq Marketplace Rules and SEC independence requirements.

The functions of this committee include, among other things:

1 unchanged sentence

• reviewing and approving the engagement of our independent auditors to perform audit services and any permissible non-audit services;

reviewing our annual and quarterly financial statements and reports, including the disclosures contained under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and discussing the statements and reports with our independent auditors and management;

• reviewing our annual and quarterly financial statements and reports, including the disclosures contained under Part II, Item 7 — Management’s Discussion and Analysis of Financial Condition and Results of Operations , and discussing the statements and reports with our independent auditors and management;

• reviewing with our independent auditors and management significant issues that arise regarding accounting principles and financial statement presentation and matters concerning the scope, adequacy and effectiveness of our financial controls;

reviewing our major financial risk exposures, including the guidelines and policies to govern the process by which risk assessment and risk management is implemented;

• reviewing our major financial risk exposures (including cybersecurity and regulatory compliance), including the guidelines and policies to govern the process by which risk assessment and risk management is implemented;

• reviewing and evaluating on an annual basis the performance of the Audit Committee, including compliance of the Audit Committee with its charter.

Our board of directors has determined that David Pfeffer qualifies

as an “audit committee financial expert” within the meaning of applicable SEC regulations and meets the financial sophistication

requirements of the Nasdaq Marketplace Rules.

Our board of directors has determined that David Pfeffer qualifies as an “Audit Committee financial expert” within the meaning of applicable SEC regulations and meets the financial sophistication requirements of the Nasdaq Marketplace Rules.

In making this determination, our board of directors has considered Mr.

extensive financial experience and business background.

Both our independent registered public accounting firm and management periodically

meets privately with our audit committee.

The audit committee had nine meetings in 2023.

committee operates under a written charter that was adopted by our board of directors and satisfies the applicable rules of the SEC

and the listing standards of the NASDAQ Stock Market.

A copy of the audit committee charter is available on our website at www.seqll.

Pfeffer’s extensive financial experience and business background.

Our independent registered public accounting firm and our management will meet privately periodically with our Audit Committee.

Compensation Committee

Our compensation committee consists of Douglas Miscoll, who is the

chair of the committee, and David Pfeffer and Patrice Milos.

Our Board has determined that each of the members of our compensation committee

satisfies the Nasdaq Marketplace Rules independence requirements.

Our Compensation Committee consists of Jeff Kurtz, chair of the committee, and David Solimine.

We have determined that each of our proposed members of our Compensation Committee satisfies the Nasdaq Marketplace Rules independence requirements.

The functions of this committee include, among other things:

1 unchanged sentence

• reviewing and approving the compensation, the performance goals and objectives relevant to the compensation, and other terms of employment of our executive officers;

reviewing and approving (or if it deems appropriate, making recommendations to the full board of directors regarding) the equity incentive plans, compensation plans and similar programs advisable for us, as well as modifying, amending or terminating existing plans and programs;

• reviewing and approving (or if it deems appropriate, making recommendations to the full board of directors regarding) the equity incentive plans, compensation plans and similar programs advisable for our company, as well as modifying, amending or terminating existing plans and programs;

• reviewing and approving the terms of any employment agreements, severance arrangements, change in control protections and any other compensatory arrangements for our executive officers;

1 unchanged sentence

• preparing the report that the SEC requires in our annual proxy statement.

None of our executive officers currently serves, or in the past fiscal

year has served, as a member of the board of directors or compensation committee of another entity that had one or more of its executive

officers serving as a member of our board of directors or compensation committee.

None of the members of our compensation committee has

been at any time one of our officers or employees.

Our compensation committee had one meeting in 2023.

compensation committee operates under a written charter that was adopted by our board of directors and satisfies the applicable

rules of the SEC and the listing standards of the NASDAQ Stock Market.

A copy of the compensation committee charter is available on

our website at www.seqll.com .

None of our executive officers currently serves, or in the past fiscal year has served, as a member of the board of directors or Compensation Committee of another entity that had one or more of its executive officers serving as a member of our board of directors or Compensation Committee.

None of the members of our Compensation Committee has at any time been one of our officers or employees or an officer or employee of Atlantic or Lyneer.

Nominating and Corporate Governance Committee

Our nominating and corporate governance committee consists of Douglas

Miscoll, who is the chair of the committee, and Patrice Milos and David Pfeffer.

Our board of directors has determined that each of the

members of this committee satisfies the Nasdaq Marketplace Rules independence requirements.

The functions of this committee include, among

other things:

Our Nominating and Corporate Governance committee consists of David Solimine, who is the chair of the committee, and Jeff Kurtz and Prateek Gattani.

We have determined that each of the members of this committee satisfies the Nasdaq Marketplace Rules independence requirements.

The functions of this committee include, among other things:

• identifying, reviewing and evaluating candidates to serve on our board of directors consistent with criteria approved by our board of directors;

evaluating director performance on our board of directors and applicable committees of our board of directors and determining whether continued service on our board of directors is appropriate;

• evaluating director performance on our board of directors and applicable committees of our board of directors and determining whether continued service on its board of directors is appropriate;

• evaluating, nominating and recommending individuals for membership on our board of directors;

• evaluating nominations by stockholders of candidates for election to our board of directors.

During 2023, our nominating and corporate governance committee met

The nominating and corporate governance committee operates under a written charter that was adopted by our board

of directors and satisfies the applicable rules of the SEC and the listing standards of the NASDAQ Stock Market.

A copy of the nominating

and corporate governance committee charter is available on our website at www.seqll.com .

Scientific Advisors

Our executive team is supported by our Scientific Advisors.

The Scientific

Advisors provide scientific advice regarding our tSMS technology to our executive team.

Each our Scientific Advisors was selected based

on experience with our tSMS technology and familiarity with our tSMS sequencers.

The Scientific Advisors are not required to provide any

particular services to us and are not currently compensated, except for periodic awards of stock options.

Efrat Shema, Ph.D.

— Principal Investigator

and Assistant Professor at the Weizmann Institute of Science.

Shema completed her M.Sc.

at the Weizmann Institute in

2007 and 2012 in molecular cell biology, after earning her B.Sc.

in life sciences at the Hebrew University in Jerusalem in 2005.

to Boston in 2012 as a Fulbright Scholar, conducting post-doctoral work under Dr.

Bradley Bernstein at Massachusetts General Hospital,

Harvard Medical School, and the Broad Institute of MIT and Harvard.

During her Ph.D.

studies at the Weizmann Institute, Dr.

received a prestigious Adams Fellowship from the Israel Academy of Sciences and Humanities, as well as the Otto Schwartz Prize for Excellence

and a UNESCO-L’OREAL national award for young women in life sciences.

Shema collaborates with us to study epigenetic events

that contribute to cellular differentiation, early development and cancer using innovative single-molecule technologies.

Claes Wahlestedt, M.D., Ph.D.

Center for Therapeutic Innovation, Leonard M.

Miller Professor and Associate Dean for therapeutic innovation at the University of

From 2005 to 2011, he was a professor and director of neuroscience at The Scripps Research Institute.

The author of over 300 papers

in scientific journals, with over 43,000 citations, Dr.

Wahlestedt has a long-standing interest in genomics and epigenetics and has

pioneered various translational efforts in these fields.

At Scripps in 2008, he co-founded CuRNA (now part of Opko Health), a spin-off

company based on his patent for targeting regulatory noncoding RNAs to up-regulate therapeutic proteins.

In 2011, he co-founded Epigenetix

Inc., a University of Miami spin-off focusing on small molecule drugs for a variety of drug targets in cancer and neuroscience.

advises us on applications development and scientific strategy.

Philipp Kapranov, Ph.D.

— Professor and Director,

Institute of Genomics at HuaQiao University, Xiamen, China.

Kapranov’s primary research interest includes systems biology

and genomics in the context of gene expression and discovery of new RNA species (both protein-coding and non-coding) and their functions,

especially in the context of human disease particularly cancer.

Kapranov received his B.Sc.

in microbial biotechnology, from

Kiev Institute of Food Industry, Ukraine, and his Ph.D.

in genetics from Michigan State University.

Previously, he was a Senior Scientist

at Affymetrix where his research first demonstrated an order of magnitude increase in transcriptional activity on human chromosomes 21

and 22 over that accounted for by previously characterized and predicted exons.

Kapranov is a long-time collaborator of ours

who purchased and deployed the first HeliScope in China, which his lab uses for researching non-coding RNA and basic science.

Code of Business Conduct and Ethics

Our board of directors has adopted a written code of conduct that applies

to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting

officer or controller, or persons performing similar functions.

A current copy of the code and all disclosures that are required by law

or Nasdaq Marketplace Rules concerning any amendments to, or waivers from, any provision of the code is posted on our website, which is

located at www.seqll.com .

Our board of directors has adopted a written code of conduct that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.

A current copy of the code and all disclosures that are required by law or Nasdaq Marketplace Rules concerning any amendments to, or waivers from, any provision of the code is posted on our website located at www.atlantic-international.com .

Board Leadership Structure

Our board of directors is free to select the Chairman of the board

of directors and a Chief Executive Officer in a manner that it considers to be in the best interests of our company at the time of selection.

Currently, Daniel Jones serves as our Chief Executive Officer and Chairman of the board of directors.

We currently believe that this leadership

structure is in our best interests.

Our board of directors is free to select the Chairman of the board of directors and a Chief Executive Officer in a manner that it considers to be in the best interests of our company at the time of selection.

Currently, Prateek Gattani serves as Chairman of the board of directors, and Jeffrey Jagid serves as the Chief Executive Officer.

We currently believe that this leadership structure is in our best interests.

As Chairman of the Board, Mr.

Jones’ key responsibilities include facilitating communication

between our board of directors and management, assessing management’s performance, managing board members, preparation of the agenda

for each board meeting, acting as chair of board meetings and meetings of our company’s stockholders and managing relations with

stockholders, other stakeholders and the public.

We will take steps to ensure that adequate structures and processes

are in place to permit our board of directors to function independently of management.

The directors will be able to request at any time

a meeting restricted to independent directors for the purposes of discussing matters independently of management and are encouraged to

do so should they feel that such a meeting is required.

Our board of directors, as a whole and also at the committee level,

plays an active role overseeing the overall management of our risks.

Our Audit Committee reviews risks related to financial and operational

items with our management and our independent registered public accounting firm.

Our board of directors is in regular contact with our

Chief Executive Officer and Chief Financial Officer, who report directly to our board of directors and who supervise day-to-day risk

Gattani’s key responsibilities include facilitating communication between our board of directors and management, assessing management’s performance, managing board members, preparation of the agenda for each board meeting, acting as chair offboard meetings and meetings of our company’s stockholders and managing relations with stockholders, other stakeholders and the public.

We will take steps to ensure that adequate structures and processes are in place to permit our board of directors to function independently of management.

The directors will be able to request at any time a meeting restricted to independent directors for the purposes of discussing matters independently of management and are encouraged to do so should they feel that such a meeting is required.

Our board of directors, as a whole, and also at the committee level, plays an active role overseeing the overall management of our risks.

Our Audit Committee reviews risks related to financial and operational items with our management and our independent registered public accounting firm.

Our board of directors is in regular contact with our Chief Executive Officer and Chief Financial Officer, who report directly to our board of directors and who supervise day-to-day risk management.

Role of Board in Risk Oversight Process

We face a number of risks, including those described herein under the

caption “Risk Factors.” Our board of directors believes that risk management is an important part of establishing, updating

and executing on our business strategy.

Our board of directors has oversight responsibility relating to risks that could affect our corporate

strategy, business objectives, compliance, operations, and the financial condition and performance.

Our board of directors focuses its

oversight on the most significant risks facing us and, on our processes, to identify, prioritize, assess, manage and mitigate those risks.

Our board of directors receives regular reports from members of our senior management on areas of material risk to us, including strategic,

operational, financial, legal and regulatory risks.

While our board of directors has an oversight role, management is principally tasked

with direct responsibility for management and assessment of risks and the implementation of processes and controls to mitigate their effects

We face a number of risks, including those described herein under Part I, Item IA — Risk Factors .

Our board of directors believes that risk management is an important part of establishing, updating and executing on our business strategy.

Our board of directors has oversight responsibility relating to risks that could affect our corporate strategy, business objectives, compliance, operations, and the financial condition and performance.

Our board of directors focuses its oversight on the most significant risks facing us and, on our processes, to identify, prioritize, assess, manage and mitigate those risks.

Our board of directors receives regular reports from members of our senior management on areas of material risk to us, including strategic, operational, financial, legal and regulatory risks.

While our board of directors has an oversight role, management is principally tasked with direct responsibility for management and assessment of risks and the implementation of processes and controls to mitigate their effects on us.

Executive Compensation

The following table sets forth total

compensation paid to our executive officers for the years ended December 31, 2023 and 2022.

Summary Compensation Table

The following table sets forth total compensation paid to our named executive officers (“NEOs”) for the years ended December 31, 2024 and 2023.

Name and Principal Position Year Salary Bonus Stock

Awards Non-Equity

Incentive Plan

Name and Principal Position

Chief Executive Officer

Chief Financial Officer

Compensation Non-Qualified

Earnings All Other

Compensation (1)

Jeffrey Jagid 2024 $ 269,231 $ 449,650 $ — $ — $ 563,833 $ 208,625 $ 1,491,339

Chief Executive

Christopher Broderick 2024 $ 161,539 $ 263,300 $ — $ — $ 272,000 $ 155,750 $ 852,589

Chief Financial

Michael Tenore 2024 $ 161,539 $ 100,000 $ — $ — $ 225,000 $ 75,000 $ 561,539

General Counsel (2)

Daniel Jones 2024 $ 102,590 $ — $ — $ — $ — $ — $ 102,590

Chief Executive

2023 $ 260,273 $ — $ — $ — $ — $ — $ 260,273

Frances Scally (4)

(1) The amounts reported in the “Option Awards” column

reflect the aggregate fair value of stock -based compensation awarded during the year computed in accordance with the provisions of the

Financial Accounting Standard Board Accounting Standards Codification Topic 718, or ASC 718.

See Note 2 to SeqLL’s consolidated

financial statements for the year ended December 31, 2022 available at www.sec.gov regarding assumptions underlying the valuation

of equity awards.

These amounts reflect the accounting cost for these stock options and do not reflect the actual economic value that

may be realized by the executive officer upon the vesting of the stock options, the exercise of the stock options, or the sale of the

common stock underlying such stock options.

(2) Of this bonus, $75,000 was deferred to, and paid in, 2022.

Jones shall resign from his positions with our company upon the completion of the Merger.

Kennedy resigned his position as our Chief Financial Officer

on August 9, 2022.

(4) The $50,000 bonus was paid in 2023.

Scally was appointed our Chief Financial Officer on August

Scally is a consultant to our company and all compensation for her services is paid to DLA, LLC, a financial consulting

firm with which Ms.

Scally is employed.

Scally shall resign from her position with our company upon the completion of the Merger.

Compensation Plan Information

The following table provides information as of December 31, 2023,

regarding our compensation plans under which equity securities are authorized for issuance:

Plan category

Securities to

Available for

2014 Equity Incentive Plan – Equity compensation plan approved by security holders

Equity compensation plans not approved by security holders

2024 $ 33,800 $ — $ — $ — $ — $ — $ 33,800

2023 $ 145,000 $ — $ — $ — $ — $ — $ 145,000

_____________

(1) All other compensation represents amounts paid related to transactions bonuses for the consummation of the Merger and auto allowances.

Transaction Bonus Auto Allowance Total

Jeffrey Jagid $ 200,000 $ 8,625 $ 208,625

Christopher Broderick $ 150,000 $ 5,750 $ 155,750

Michael Tenore $ 75,000 $ — $ 75,000

Jagid, Broderick and Tenore became executive officers of the Company upon completion of the Merger on June 18, 2024.

Jones resigned from all positions with the Company upon completion of the Merger.

Scally was a consultant to the Company and all compensation of the services were paid to DLA, LLC, a financial consulting firm with which Ms.

Scully is employed.

Scully resigned from her position with the Company upon the completion of the Merger.

Employment and Consulting Agreements

Consulting Agreement with Robert Machinist

Upon the closing of the Merger, Robert Machinist entered into a one-year consulting agreement with our company as Executive Vice Chairman of the Board.

Machinist’s consulting fee is $180,000 per annum.

Machinist is entitled to a pro-rated true-up payment from his Consulting Agreement dated October 15, 2022 with Atlantic Acquisition corp.

Machinist is also entitled to a $100,000 transaction bonus upon the completion of the Merger.

Machinist is eligible for discretionary annual bonuses as determined by the compensation committee of our board of directors.

If the consulting agreement is terminated for any reason other than for Cause (as defined) or if Mr.

Machinist voluntarily terminates his consulting engagement for any reason, he will be entitled to full benefits and all previously granted restricted stock, restricted stock units and warrants will immediately vest.

He will be entitled to six months of severance payments of his base salary upon termination, in equal monthly installments, other than for Cause.

For Cause, he will be entitled to three months of severance paid in three equal monthly installments, and all unvested restricted stock, restricted stock units and warrants then held by Mr.

Machinist will be forfeited.

Employment Agreement with Jeffrey Jagid

Upon the closing of the Merger, Jeffrey Jagid entered into an employment agreement with our Company as Chief Executive Officer.

The agreement is for a term of five years with an additional one-year extension unless terminated by either party upon 90 days written notice prior to the end of the initial term.

Jagid’s base salary is $500,000 per annum.

Jagid is entitled to a true-up payment in an amount equal to the pro-rated difference between his salary of $120,000 per year under his employment contract dated February 1, 2023 with Atlantic and $500,000 per annum.

Jagid is eligible to receive an annual bonus in an amount equal to his base salary for every year commencing in 2023.

The bonus will be predicated upon our recording a minimum of $250,000,000 in revenues.

Jagid will also be paid a $200,000 transaction bonus as a result of the closing of the Merger, and he will be paid additional transaction bonuses in the amount of $100,000 for the closing of any subsequent acquisition that is valued in excess of $8,000,000.

He is also eligible for an annual discretionary bonus to be set by the compensation committee of our board of directors.

If we terminate the employment agreement for any reason other than Cause (as defined), all of Mr.

Jagid’s then-outstanding restricted stock, restricted stock units and warrants will immediately vest, and Mr.

Jagid will be entitled to (i) 12 months of severance payments of his base salary, (ii) a prorated annual bonus if we are on pace to meet the above-stated performance milestones, (iii) the right to 12 months of COBRA insurance, and (iv) reasonable outplacement services for a period of up to 90 days from termination.

Upon death or disability, Mr.

Jagid, or his estate, will receive all accrued compensation and any prorated bonus, and any equity that would have vested during the 24-month period beginning on the date of death or disability will immediately vest.

Jagid is terminated for Cause, or resigns without Good Reason (as defined), he will receive accrued compensation and any vested equity.

Upon a Change of Control (as defined), all of Mr.

Jagid’s non-vested equity will immediately vest in full, and he will be entitled to his full severance payments stated above if he chooses to terminate his employment with our company.

Jagid will be subject to a one-year non-compete covenant from termination of his employment anywhere in the United States if termination is for Cause, and six months if termination is for any other reason.

He will be subject to a two-year non-solicitation covenant from termination if he is terminated for Cause and 12 months if he is terminated for any other reason.

He will also be covered under our directors and officers’ liability insurance for up to one year from termination of his employment.

Employment Agreement with Christopher Broderick

Upon the closing of the Merger, Christopher Broderick entered into an employment agreement with our company as Chief Financial Officer.

The employment agreement is for three years with an additional one-year extension unless terminated by either party upon 90 days’ written notice prior to the end of the initial term.

Broderick’s base salary is $300,000 per annum.

He is also entitled to a true-up payment equal to the pro-rated difference between his salary of $120,000 per year under his employment agreement dated February 1, 2023 with Atlantic and $300,000 per annum.

Broderick will be eligible to receive a yearly bonus equal to his annual base salary for every year commencing in 2023.

The bonus will be predicated upon our recording a minimum of $250,000,000 in revenues and adjusted EBITDA of $5,000,000.

Broderick will also be paid a $150,000 transaction bonus as a result of the closing of the Merger and he will be paid additional transaction bonuses in the amount of $75,000 for the closing of any subsequent acquisition that is valued in excess of $8,000,000.

He also will be eligible for an annual discretionary bonus to be set by the compensation committee of the board of directors.

If we terminate the employment agreement for any reason other than Cause (as defined), all of Mr.

Broderick’s then-outstanding restricted stock, restricted stock units and warrants will immediately vest, and Mr.

Broderick will be entitled to (i) 12 months of severance payments of his base salary, (ii) a prorated annual bonus if we are on pace to meet the above-

stated performance milestones, (iii) the right to 12 months of COBRA insurance, and (iv) reasonable outplacement services for a period of up to 90 days from termination.

Upon death or disability, Mr.

Broderick, or his estate, will receive all accrued compensation and any prorated bonus, and any equity that would have vested during the 24-month period beginning on the date of death or disability will immediately vest.

Broderick is terminated for Cause, or resigns without Good Reason (as defined), he will receive accrued compensation and any vested equity.

Upon a Change of Control (as defined), all of Mr.

Broderick’s non-vested equity will immediately vest in full, and he will be entitled to his full severance payments stated above if he chooses to terminate his employment with our company.

Broderick will be subject to a one-year non-compete covenant from termination of his employment anywhere in the United States if termination is for Cause, and six months if his termination is for any other reason.

He will be subject to a two-year non-solicitation covenant from termination if he is terminated for Cause and 12 months if he is terminated for any other reason.

He will also be covered under our directors and officers’ liability insurance for up to one year from termination of employment.

Employment Agreement with Michael Tenore

Upon the closing of the Merger, Michael Tenore entered into an employment agreement with our company as General Counsel and Secretary.

The employment agreement is for three years with an additional one-year extension unless terminated by either party upon 90 days written notice prior to the end of the initial term.

Tenore’s base salary is $300,000 per annum.

He is also entitled to a true-up payment equal to the pro-rated difference between his salary of $120,000 per year under his employment agreement dated April 1, 2023, with Atlantic and $300,000 per annum.

Tenore is entitled to receive an annual bonus of $100,000 for every year commencing in 2023.

The bonus is predicated upon our receiving a minimum of $250,000,000 in revenues and adjusted EBITDA of $5,000,000.

Tenore will also be paid a $75,000 transaction bonus as a result of the closing of the Merger, and he will be paid additional transaction bonuses in the amount of $75,000 for the closing of any subsequent acquisition that is valued in excess of $8,000,000.

He also will be eligible for an annual discretionary bonus to be set by the compensation committee of our board of directors.

If we terminate the employment agreement for any reason other than Cause (as defined), all of Mr.

Tenore’s then-outstanding restricted stock, restricted stock units and warrants will immediately vest, and Mr.

Tenore will be entitled to (i) 12 months of severance payments of his base salary, (ii) a prorated annual bonus if we are on pace to meet the above-stated performance milestones, (iii) the right to 12 months of COBRA insurance, and (iv) reasonable outplacement services for a period of up to 90 days from termination.

Upon death or disability, Mr.

Tenore, or his estate, will receive all accrued compensation and any prorated bonus, and any equity that would have vested during the 24-month period beginning on the date of death or disability will immediately vest.

Tenore is terminated for Cause, or resigns without Good Reason (as defined), he will receive accrued compensation and any vested equity.

Upon a Change of Control (as defined), all of Mr.

Tenore’s non-vested equity will immediately vest in full and he will be entitled to his full severance payments stated above if he chooses to terminate his employment with our company.

Tenore will be subject to a one-year non-compete covenant from termination of his employment anywhere in the United States if his termination is for Cause, and six months if termination is for any other reason.

He will be subject to a two-year non-solicitation covenant from termination if he is terminated for Cause and 12 months if terminated for any other reason.

He also will be covered under our directors and officers’ liability insurance for up to one year from termination of employment.

Employment Agreement with Todd McNulty

On June 18, 2024, Lyneer entered into a new employment agreement, with Todd McNulty to be its Chief Executive Officer.

The employment agreement is for three years with successive one-year extensions unless terminated by either party upon 90 days’ prior written notice.

McNulty’s current base salary is $750,000 per annum.

McNulty is entitled to receive:

(a) a transaction bonus of $100,000;

(b) accrued compensation of $300,000 on or before June 28, 2024;

(d) an additional cash bonus of $1,375,000 on or before December 18, 2024;

(e) beginning in 2024 and each fiscal year thereafter an annual bonus increasing from $100,000 to $300,000 on total revenues increasing from $350 million to $390 million, and (f) restricted stock units equal to 1% of the Company’s issued and outstanding shares of common stock.

He is also eligible for an annual discretionary bonus to be set by the compensation committee of our board of directors.

In case of termination without Cause (as defined), or termination by Mr.

McNulty with Good Reason (as defined), or termination upon expiration date with notice of termination/non-renewal by Lyneer, unless Lyneer provides notice of termination prior to the expiration of the Agreement in which case Mr.

McNulty shall receive the severance amount.

McNulty will be entitled to severance defined as:

(i) in the event of a termination date on or prior to the second anniversary date of the Merger, an amount equal to 1.5 times his annual base salary as in effect immediately prior to the termination date, and continuation of medical insurance benefits, as provided on the termination date until the end of the applicable severance term (as defined, or, at the sole discretion of Lyneer, reimburse Mr.

McNulty for COBRA insurance;

(ii) in the event of a termination date after the second anniversary of the Merger, an amount equal to one time his annual base salary as in effect immediately prior to the termination date, and continuation of medical insurance benefits or COBRA insurance until the end of the applicable severance term;

or (iii) in the case of non-renewal of the employment agreement by Lyneer after the initial term or any renewal term and the subsequent termination of employment within three months following such non-renewal of the employment agreement by Lyneer, an amount equal to six months of his annual base salary as in effect immediately prior to the termination date, and continuation of medical insurance benefits or COBRA insurance.

In case of termination by Lyneer with Cause or by Mr.

McNulty without Good Reason, Mr.

McNulty will only be entitled to accrued obligations consisting of accrued but unpaid base salary;

unreimbursed expenses;

accrued but unpaid benefits;

and any unpaid bonus for any then completed fiscal year.

McNulty is subject to one-year non-compete and non-solicitation covenants from termination of his employment.

Employment Agreement with James Radvany

On June 18, 2024, Lyneer entered into a new employment agreement with James Radvany to continue as its Chief Financial Officer.

The employment agreement has a term of three years with successive one-year extensions unless terminated by either party upon 90 days’ prior written notice.

Radvany’s base salary is $500,000 per annum.

Radvany is entitled to the same transactions bonus, accrued compensation, 2024 Special Bonuses, annual bonuses starting in 2024, discretionary bonuses and 1% restricted stock units as Mr.

McNulty is entitled to.

Radvany’s employment agreement provides for the same severance provisions, non-competition and non-solicitation covenants as those in Mr.

Radvany’s employment agreement discussed above.

In case of termination by Lyneer with Cause or by Mr.

Radvany without Good Reason, Mr.

Radvany will only be entitled to accrued obligations consisting of accrued but unpaid base salary;

unreimbursed expenses;

accrued but unpaid benefits;

and any unpaid bonus for any then completed fiscal year.

Board of Directors Agreement (Chairman) with Prateek Gattani

Upon the closing of the Merger, the Company adopted the Board of Director’s Agreement dated as of April 15, 2024 with Prateek Gattani to serve as Chairman of the Board for a two-year period from the closing of the Merger.

The agreement provides for Mr.

Gattani to have all responsibilities of a director of the Company.

He is to be paid an annual fee equal to the higher of $200,000 or the highest amount any other director is being paid.

Gattani was granted RSUs to purchase 1,300,000 shares of common stock vested upon the date of grant and exercisable for five (5) years from the date of issuance.

The agreement provides that he cannot be removed except by the Company’s stockholders.

2023 Equity Incentive Plan

Our board of directors and our stockholders originally approved our

2014 Equity Incentive Plan, or the 2014 Plan, in April 2014.

Our 2014 Plan allows for the grant of equity-based awards to our and

our affiliates’ officers, employees, directors and key persons.

On March 18, 2021, our board of directors and stockholders

approved an amendment and restatement of our 2014 Plan to increase the number of shares of common stock available for equity awards under

the 2014 plan to 87,500 shares.

The description below is of our 2014 Plan as amended and restated, except as otherwise noted.

The purpose of our 2014 Plan, as amended and

restated, is to encourage and enable our and our affiliates’ officers, employees, directors and other key persons (including consultants

and prospective employees) upon whose judgment, initiative and efforts we largely depend for the successful conduct of our business to

acquire a proprietary interest in our company.

Participants in our 2014 Plan may include

full or part-time officers, employees, directors and key persons (including advisors and consultants) of our company or our affiliates

who are selected to receive awards from time to time by the administrator in its sole discretion.

The Atlantic International Corp.

2023 Equity Incentive Plan (the “Incentive Plan”) became effective upon the consummation of the Merger and allows us to provide equity awards as part of our compensation program, an important tool for motivating, attracting and retaining talented employees and for providing incentives that promote our business and increased stockholder value.

The following is a summary of the material features of the Incentive Plan.

This summary is qualified in its entirety by the full text of the Incentive Plan.

The purpose of the Incentive Plan is to enhance our ability to attract, retain and motivate persons who make (or are expected to make) important contributions to our Company by providing these individuals with equity ownership opportunities and/or equity-linked compensatory opportunities.

Persons eligible to participate in the Incentive Plan are our officers, employees, non-employee directors, and consultants and those of our subsidiaries as selected from time to time by the plan administrator in its discretion.

date of this Annual Report, approximately 314 individuals currently employed by, or affiliated with, Atlantic or Lyneer are eligible to participate in the Incentive Plan, which includes four officers, approximately 300 employees who are not officers, seven non-employee directors, and three consultants.

Administration

Our 2014 Plan is administered by our

compensation committee, or, if at any time our compensation committee is not in existence, our board of directors.

In addition, to the

extent applicable law permits, our board of directors may delegate any of its authority under our 2014 Plan to another committee or one

or more officers, and our compensation committee may delegate any of its authority hereunder to a sub-committee or to one or more officers,

except that no such delegation is permitted with respect to awards made to individuals who are subject to Section 16 of the Exchange Act

unless the delegation is to another committee consisting entirely of “nonemployee directors” within the meaning of Rule 16b-3

of the Exchange Act.

Subject to the provisions of our 2014 Plan, the administrator has the power to administer the plan, including

but not limited to, the power to select the eligible officers, employees, directors, and key employees to whom awards are granted;

determine the number of shares to be covered by each award;

to determine the terms and conditions of any award and to amend any outstanding

Authorized Shares.

As of December 31, 2023, a total of 87,500 shares of our common

stock were authorized for issuance under our 2014 Plan, and at such date, stock grants of an aggregate of 67,845shares had been made under

the 2014 Plan, and 19,655 shares authorized under the 2014 Plan remained available for award purposes.

All of the authorized shares

may be issued pursuant to incentive stock options.

The shares available for issuance may be authorized but unissued shares or shares reacquired

by us and held in its treasury.

The share reserve under our 2014 Plan is depleted by the maximum number of shares, if any, that may be

issuable under an award as determined at the time of grant.

However, awards that may only be settled in cash (determined at the time of

grant) do not deplete the share reserve.

If (1) an award lapses, expires, terminates or is cancelled without

the issuance of shares, (2) it is determined during or at the conclusion of the term of an award that all or some portion of the

shares with respect to which the award was granted will not be issuable on the basis that the conditions for such issuance will not be

satisfied, (3) shares are forfeited under an award, (4) shares are issued under any award and we subsequently reacquire them

pursuant to rights reserved upon the issuance, (5) an award or a portion thereof is settled in cash, or shares are withheld by us

in payment of the exercise price or withholding taxes of an award, then such shares will be recredited to the reserve and may again be

used for new awards.

However, shares recredited to reserve pursuant to clause (4) in the preceding sentence may not be issued pursuant

to incentive stock options.

Adjustments to Shares.

If, as a result of any reorganization,

recapitalization, reclassification, stock dividend, stock split, reverse stock split or other similar change in our capital stock, the

outstanding shares are increased or decreased or are exchanged for a different number or kind of shares or other securities of our company,

or additional shares or new or different shares or other securities of our company or other non-cash assets are distributed with respect

to such shares or other securities, or, if, as a result of any merger, consolidation or sale of all or substantially all of our assets,

the outstanding shares are converted into or exchanged for a different number or kind of securities of our company or any successor entity

(or a parent or subsidiary thereof), the administrator will make an appropriate or proportionate adjustment in (1) the maximum number

of shares reserved for issuance under our 2014 Plan;

(2) the number and kind of shares or other securities subject to any then outstanding

awards under our 2014 Plan;

and (3) the exercise price for each share subject to any then outstanding stock options.

The administrator

also may adjust the number of shares subject to outstanding awards and the exercise price and the terms of outstanding awards to take

into consideration material changes in accounting practices or principles, extraordinary dividends, acquisitions or dispositions of stock

or property or any other event if it is determined by the administrator that such adjustment is appropriate to avoid distortion in the

operation of our 2014 Plan, subject to the limitations described in our 2014 Plan.

Effect of a Sale Event.

Unless otherwise provided in

an award or other agreement, upon a “sale event,” if the successor or surviving corporation (or parent thereof) so agrees,

then, without the consent of any holder of an award (or other person with rights in an award), some or all outstanding awards may be assumed,

or replaced with the same type of award with similar terms and conditions, subject to adjustments described in our 2014 Plan, by the successor

or surviving corporation (or parent thereof) in the sale event.

A “sale event” is generally defined for this purpose as (1) any

person becoming the beneficial owner of 50% or more of the combined voting power of our then-outstanding securities (subject to exceptions

and other limitations scribed in our 2014 Plan), (2) our stockholders approving a plan of complete liquidation or dissolution of

our company, (3) the consummation of (a) an agreement for the sale or disposition of all or substantially all of our assets

(other than to certain excluded persons), (b) a merger, consolidation or reorganization of our company with or involving any other

corporation (subject to specified exceptions), or (4) a change in the majority of our board of directors that is not approved by

a supermajority of the existing board.

More detailed descriptions and additional information on limitations relating to each of these

sale events are in our 2014 Plan.

If, after a sale event in which the awards are assumed or replaced,

the award holder experiences a termination event as a result of a termination of service without cause, due to death or disability, or

as a result of a resignation for good reason, in each case within 24 months after a sale event, then the award holder’s awards

will be vested in full or deemed earned in full (assuming target performance, if applicable).

To the extent the awards are not assumed or replaced in the sale event,

then, (1) each option will become immediately and fully vested and, unless the administrator determines otherwise, will be canceled

on the sale event in exchange for a cash payment equal to the excess of the price paid in the sale event over the exercise price of the

option, and all options with an exercise price lower than the price paid in the sale event will be canceled for no consideration, (2) restricted

stock and restricted stock units (not subject to performance goals) will be vested in full and settled, along with any accompanying

dividend equivalent units, and (3) all awards subject to performance goals with outstanding performance periods will be canceled

in exchange for a cash payment equal to the amount that would have been due under the award if performance had been satisfied at the better

of target or the performance trend through the sale event.

Limit on Director Awards.

The maximum value of awards

granted during a single fiscal year to any non-employee director, taken together with any cash fees paid during the fiscal year to the

non-employee director in respect of the director’s service as a member of our board of directors during such year (including service

as a member or chair of any committees of the board), shall not exceed $800,000 in total value for the first year of service and $400,000

for future years of service (calculating the value of any such awards based on the grant date fair value of such awards for financial

reporting purposes).

The Incentive Plan is administered by the Compensation Committee of our board of directors, our board of directors or such other similar committee pursuant to the terms of the Incentive Plan.

The plan administrator, which initially is the Compensation Committee of our board of directors, has full power to select, from among the individuals eligible for awards, the individuals to whom awards will be granted, to make any combination of awards to participants, and to determine the specific terms and conditions of each award, subject to the provisions of the Incentive Plan.

The plan administrator may delegate to one or more of our officers, the authority to grant awards to individuals who are not subject to the reporting and other provisions of Section 16 of the Exchange Act.

Share Reserve

A number of shares of our common stock equal to 15% (initially 7,309,322 shares) of the number of shares of common stock to be outstanding immediately following consummation of the Initial Capital Raise following the Merger was initially reserved for issuance under the Incentive Plan.

Following the Merger, we assumed Atlantic’s obligations with respect to restricted stock units granted to and held by those members of Atlantic management and certain persons who are key consultants to our company post-Merger.

Shares underlying any awards under the Incentive Plan that are forfeited, cancelled, held back to cover the exercise price or tax withholding, satisfied without the issuance of stock or otherwise terminated (other than by exercise) will be added back to the shares available for issuance under the Incentive Plan.

The payment of dividend equivalents in cash shall not count against the share reserve.

Annual Limitation on Awards to Non-Employee Directors

The Incentive Plan contains a limitation whereby the grant date value of all awards under the Incentive Plan and all other cash compensation paid by us to any non-employee director may not exceed $250,000 in any calendar year, although our board of directors may, in its discretion, make exceptions to the limit in extraordinary circumstances.

Types of Awards

Awards under our 2014 Plan may consist

of incentive stock options, non-qualified stock options, restricted stock awards, unrestricted stock awards, restricted stock units,

or any combination of those awards.

Some provisions of our 2014 Plan relating to these award types are summarized below.

The Incentive Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalents, and other stock or cash-based awards, or collectively, awards.

Unless otherwise set forth in an individual award agreement, each award shall vest over a four-year period, with one-quarter of the award vesting on the first annual anniversary of the date of grant, with the remainder of the award vesting monthly thereafter.

Stock Options

A stock option is an award entitling the

recipient to acquire shares, at such exercise price as determined by the administrator (which may not be lower than the fair market value

of the underlying shares on the date of grant) and subject to such restrictions and conditions as the administrator may determine at the

time of grant.

Conditions may be based on continuing employment (or other service relationship) and/or achievement of pre-established

performance goals and objectives.

Stock options granted under our 2014 Plan may be either non-qualified stock options or incentive stock

Incentive stock options may be granted only to our employees or employees of our subsidiaries, and must certain requirements

specified in our 2014 Plan and the Code.

Stock options will become exercisable at such time or times as determined by the administrator

at or after the grant date and set forth in the stock option agreement.

The administrator may at any time accelerate the exercisability

of all or any portion of any stock option.

The Incentive Plan permits the granting of both options to purchase shares of our common stock intended to qualify as incentive stock options under Section 422 of the Code and options that do not so qualify.

Options granted under the Incentive Plan will be nonqualified options if they fail to qualify as incentive stock options or exceed the annual limit on incentive stock options.

Incentive stock options may only be granted to our employees and employees of our subsidiaries.

Nonqualified options may be granted to any persons eligible to receive awards under the Incentive Plan.

The exercise price of each option will be determined by the plan administrator but generally may not be less than 100% of the fair market value of the common stock on the date of grant or, in the case of an incentive stock option granted to a 10% stockholder, 110% of such share’s fair market value.

The term of each option will be fixed by the plan administrator and may not exceed ten years from the date of grant (or five years for an incentive stock option granted to a 10% stockholder).

The plan administrator will determine at what time or times each option may be exercised, including the ability to accelerate the vesting of such options.

Upon exercise of options, the exercise price must be paid in full either in cash, check, or, with the approval of the plan administrator, by delivery (or attestation to the ownership) of shares of common stock that are beneficially owned by the optionee free of restrictions or were purchased in the open market.

Subject to applicable law and approval of the plan administrator, the exercise price may also be made by means of a broker-assisted cashless exercise.

In addition, the plan

administrator may permit nonqualified options to be exercised using a “net exercise” arrangement that reduces the number of shares issued to the optionee by the largest whole number of shares with fair market value that does not exceed the aggregate exercise price.

Stock Appreciation Rights

The plan administrator may award stock appreciation rights subject to such conditions and restrictions as it may determine.

Stock appreciation rights entitle the recipient to shares of common stock, or cash, equal to the value of the appreciation in our stock price over the exercise price.

The exercise price generally may not be less than 100% of the fair market value of common stock on the date of grant.

The term of each stock appreciation right will be fixed by the plan administrator and may not exceed ten years from the date of grant.

The plan administrator will determine at what time or times each stock appreciation right may be exercised, including the ability to accelerate the vesting of such stock appreciation rights.

Restricted Stock

A restricted stock award is a grant

(or sale, at such purchase price as determined by the administrator) of shares that are subject to such restrictions and conditions as

the administrator may determine at the time of grant.

Conditions may be based on continuing employment (or other service relationship)

or achievement of pre-established performance goals and objectives.

The terms and conditions of each such agreement shall be determined

by the administrator.

Unrestricted Stock.

The administrator may grant (or sell

at par value or such higher purchase price determined by the administrator) unrestricted shares, in respect of past services, in exchange

for cancellation of a compensation right, as a bonus, or any other valid consideration, or in lieu of any cash compensation due to such

Restricted Stock Units and Dividend Equivalent Units.

administrator may grant restricted stock units representing the right to receive a future payment of cash, the amount of which is

determined by reference to our shares, shares or a combination of cash and shares.

The administrator will determine all terms and conditions

of an award of restricted stock units, including but not limited to the number granted, in what form they will be settled, whether

performance goals must be achieved for the restricted stock units to be earned, the length of any vesting or performance period and

the date of payment, and whether the grant will include dividend equivalent units.

The administrator will determine all terms and

conditions of an award of dividend equivalent units, including whether payment will be made in cash or shares.

However, no dividend

equivalent units may be paid with respect to restricted stock units that are not earned or that do not become vested.

Termination of Employment or Service.

Except as otherwise

provided in any award agreement or an award holder’s employment offer letter, severance letter or services agreement, or as determined

by administrator at the time of the award holder’s termination of employment or service:

If the termination is for cause, the award holder will forfeit all outstanding awards immediately upon termination and will not be permitted to exercise any stock options following termination.

If the termination is due to the award holder’s death or disability (when the award holder could not have been terminated for cause), the award holder will forfeit the unvested portion of any award, and any vested stock options will remain exercisable until the earlier of the original stock option expiration date or 12 months from the date of termination.

If the termination was for any reason other than cause, death or disability (when the award holder could not have been terminated for cause), the award holder will forfeit the unvested portion of any award, and any vested stock options will remain exercisable until the earlier of the original stock option expiration date or three months from the date of termination.

Term of Plan and Plan Amendments.

Our 2014 Plan will

continue until all shares reserved for issuance under our 2014 Plan have been issued, or, if earlier, until such time as the administrator

terminates our 2014 Plan as described below.

No incentive stock options may be granted after the ten (10) year anniversary of the

date of stockholder approval of the amendment and restatement of our 2014 Plan unless the stockholders have approved an extension.

Our board of directors may, at any time, amend, terminate or discontinue

our 2014 Plan, except that our stockholders must approve any amendment to the extent approval is required by Section 16 of the Exchange Act,

the Code, the listing requirements of any principal securities exchange or market on which our shares are then traded or any other applicable

In addition, stockholders must approve any amendment to our 2014 Plan that would materially increase the number of shares reserved

(except as permitted by the adjustment provisions of our 2014 Plan) or that would diminish the protections afforded by the anti-repricing

provisions of our 2014 Plan.

Any termination of our 2014 Plan will not affect the authority of our

board of directors and the administrator to administer outstanding awards or affect the rights of award holders with respect to awards

previously granted to them.

Award Amendments, Cancellation and Disgorgement.

to the anti-repricing and other requirements of our 2014 Plan, the administrator may modify, amend or cancel any award.

However, except

as otherwise provided in our 2014 Plan or an award agreement, the consent of the award holder is required to any amendment that materially

diminishes the holder’s rights under the award.

Our 2014 Plan includes exceptions to the consent requirement for actions necessary

to comply with applicable law or the listing requirements of securities exchanges, to preserve favorable accounting or tax treatment of

any award for our company or to the extent the administrator determines that an action does not materially and adversely affect the value

of the award or is in the best interest of the affected award holder or any other person who has an interest in the award.

The administrator has full power and authority to terminate or cause

an award holder to forfeit an award, and require an award holder to disgorge to us, any gains attributable to the award, if the award

holder engages in any action constituting, as determined by the administrator in its discretion, cause for termination, or a breach of

any award agreement or any other agreement between the award holder and us or one of our affiliates concerning noncompetition, non-solicitation,

confidentiality, trade secrets, intellectual property, non-disparagement or similar obligations.

In addition, any awards granted pursuant

to our 2014 Plan, and any shares issued or cash paid pursuant to an award, will be subject to any recoupment or claw-back policy that

is adopted by us from time to time, or any recoupment or similar requirement otherwise made applicable to us by law, regulation or listing

Repricing and Backdating Prohibited.

Notwithstanding

anything in our 2014 Plan to the contrary, and except for the adjustments provided for in our 2014 Plan, neither the administrator nor

any other person may (1) amend the terms of outstanding stock options to reduce the exercise or grant price of such outstanding stock

(2) cancel outstanding stock options in exchange for stock options with an exercise or grant price that is less than the

exercise or grant price of the original stock options;

or (3) cancel outstanding stock options with an exercise or grant price above

the current fair market value of a share in exchange for cash or other securities.

In addition, the administrator may not make a grant

of a stock option with a grant date that is effective prior to the date the administrator takes action to approve the award.

Incentive Plan Awards

We did not make any stock option grants to our executive officers during

the fiscal year ended December 31, 2023.

The plan administrator may award restricted shares of common stock subject to such conditions and restrictions as it may determine.

These conditions and restrictions may include the achievement of certain performance goals and/or continued employment with our Company or our subsidiaries through a specified vesting period.

Unless otherwise provided in the applicable award agreement, the participant generally will have the rights and privileges of a stockholder as to such restricted shares, including without limitation the right to vote such restricted shares and the right to receive dividends, if applicable.

Restricted Stock Units and Dividend Equivalents

The plan administrator may award restricted stock units which represent the right to receive common stock at a future date in accordance with the terms of such grant upon the attainment of certain conditions specified by the plan administrator.

Restrictions or conditions could include, but are not limited to, the attainment of performance goals, continuous service with our Company or our subsidiaries, the passage of time or other restrictions or conditions.

The plan administrator determines the persons to whom grants of restricted stock units are made, the number of restricted stock units to be awarded, the time or times within which awards of restricted stock units may be subject to forfeiture, the vesting schedule, and rights to acceleration thereof, and all other terms and conditions of the restricted stock unit awards.

The value of the restricted stock units may be paid in shares of common stock, cash, other securities, other property, or a combination of the foregoing, as determined by the plan administrator.

A participant holding restricted stock units will have no voting rights as a stockholder.

Prior to settlement or forfeiture, restricted stock units awarded under the Incentive Plan may, at the plan administrator’s discretion, provide for a right to dividend equivalents.

Such right entitles the holder to be credited with an amount equal to all dividends paid on one share of common stock while each restricted stock unit is outstanding.

Dividend equivalents may be converted into additional restricted stock units.

Settlement of dividend equivalents may be made in the form of cash, shares of common stock, other securities, other property, or a combination of the foregoing.

Prior to distribution, any dividend equivalents will be subject to the same conditions and restrictions as the restricted stock units to which they attach.

Other Stock or Cash Based Awards

Other stock or cash-based awards may be granted either alone, in addition to, or in tandem with, other awards granted under the Incentive Plan and/or cash awards made outside of the Incentive Plan.

The plan administrator will have authority to determine the persons to whom and the time or times at which such awards will be made, the amount of such awards, and all other conditions, including any dividend and/or voting rights.

Changes in Capital Structure

The Incentive Plan requires the plan administrator to make appropriate adjustments to the number of shares of common stock that are subject to the Incentive Plan, to certain limits in the Incentive Plan, and to any outstanding awards to reflect stock dividends, stock splits, extraordinary cash dividends and similar events.

Change in Control

Except as set forth in an award agreement issued under the Incentive Plan, in the event of a change in control (as defined in the Incentive Plan), each outstanding stock award (vested or unvested) will be treated as the plan administrator determines, which may include (i) our continuation of such outstanding stock awards (if we are the surviving corporation);

(ii) the assumption of such outstanding stock awards by the surviving corporation or its parent;

(iii) the substitution by the surviving corporation or its parent of new stock options or other equity awards for such stock awards;

(iv) the cancellation of such stock awards in exchange for a payment to the participants equal to the excess of (A) the fair market value of the shares subject to such stock awards as of the closing date of such corporate transaction over (B) the exercise price or purchase price paid or to be paid (if any) for the shares subject to the stock awards (which payment may be subject to the same conditions that apply to the consideration that will be paid to holders of shares in connection with the transaction, subject to applicable law);

(v) provide that such award shall vest and, to the extent applicable, be exercisable as to all shares covered thereby, notwithstanding anything to the contrary in the Incentive Plan or the provisions of such award;

or (vi) provide that the award will terminate and cannot vest, be exercised or become payable after the applicable event.

The Incentive Plan provides that a stock award may be subject to additional acceleration of vesting and exercisability upon a change in control as may be provided in the award agreement for such stock award, but in the absence of such provision, no such acceleration will occur.

Tax Withholding

Participants in the Incentive Plan are responsible for the payment of any federal, state or local taxes that we or our subsidiaries are required by law to withhold upon the exercise of options or stock appreciation rights or vesting of other awards.

The plan administrator may cause any tax withholding obligation of our company or our subsidiaries to be satisfied, in whole or in part, by the applicable entity withholding from shares of common stock to be issued pursuant to an award a number of shares with an aggregate fair market value that would satisfy the withholding amount due.

The plan administrator may also require any tax withholding obligation of our company or our subsidiaries to be satisfied, in whole or in part, by an arrangement whereby a certain number of shares issued pursuant to any award are immediately sold and proceeds from such sale are remitted to us or our subsidiaries in an amount that would satisfy the withholding amount due.

Transferability of Awards

The Incentive Plan generally does not allow for the transfer or assignment of awards, other than by will or by the laws of descent and distribution;

however, the plan administrator has the discretion to permit awards (other than incentive stock options) to be transferred by a participant.

The Incentive Plan, unless terminated earlier, will continue in effect for a term of ten (10) years, after which time no awards may be granted under the Incentive Plan.

Amendment and Termination

Our board of directors and the plan administrator may each amend, suspend, or terminate the Incentive Plan and the plan administrator may amend or cancel outstanding awards, but no such action may materially and adversely affect rights under an award without the holder’s consent.

Certain amendments to the Incentive Plan will require the approval of our stockholders.

Generally, without stockholder approval, (i) no amendment or modification of the Incentive Plan may reduce the exercise price of any stock option or stock appreciation right, (ii) the plan administrator may not cancel any outstanding stock option or stock appreciation right where the fair market value of the common stock underlying such stock option or stock appreciation right is less than its exercise price and replace it with a new option or stock appreciation right, another award or cash and (iii) the plan administrator may not take any other action that is considered a “repricing” for purposes of the stockholder approval rules of the applicable securities exchange.

Clawback Policy

All stock awards granted under the Incentive Plan are subject to recoupment in accordance with any clawback policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the U.S.

Dodd-Frank Wall Street Reform and Consumer Protection

Act or other applicable law.

In addition, our board of directors may impose such other clawback, recovery or recoupment provisions in a stock award agreement as our board of directors determines necessary or appropriate.

Grants of Plan Based Awards

The following table set forth supplemental information relating to the Company’s grants of RSUs during the fiscal year 2024 to the NEOs.

Also included, in accordance with SEC rules on disclosure of executive compensation, is information relating to the estimated grant date fair value of the grants.

Neither the values reflected in the table, nor the assumptions utilized in arriving the values should be considered indicative of future stock performance.

Stock Awards:

Stock Grant Date

Name/Grant Type Grant

Jeffrey Jagid

RSU N/A — $ —

Christopher Broderick

RSU N/A — $ —

Michael Tenore

RSU N/A — $ —

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth outstanding equity awards to our named

executive officers as of December 31, 2023.

Option Awards

Unexercisable

Number of Shares or

The following table sets forth outstanding equity awards to our NEOs as of December 31, 2024.

Name Number of Shares or Units of

Stock that have not Vested Market Value of Shares or Units of

Stock that have not Vested

Jeffrey Jagid — $

Christopher Broderick — $ —

Michael Tenore — $ —

Director Compensation

The following discussion describes the significant

elements of the expected compensation program for members of our board of directors and its committees.

The compensation of our directors

is designed to attract and retain committed and qualified directors and to align their compensation with the long-term interests

of our shareholders.

Directors who are also executive officers (each, an “Excluded Director”) will not be entitled to receive

any compensation for his or her service as a director, committee member or Chair of our board of directors or of any committee of our

board of directors.

The following discussion describes the significant elements of the existing compensation program for members of our current board of directors and its committees.

The compensation of our directors is designed to attract and retain committed and qualified directors and to align their compensation with the long-term interests of our stockholders.

Directors who are also executive officers (each, an “Excluded Director”) will not be entitled to receive any compensation for his or her service as a director, committee member or Chair of our board of directors or of any committee of our board of directors.

Director Compensation Arrangements.

Our non-employee director

compensation program is designed to attract and retain qualified individuals to serve on our board of directors.

Our board of directors,

on the recommendation of our compensation committee, will be responsible for reviewing and approving any changes to the directors’

compensation arrangements.

In consideration for serving on our board of directors, each director (other than Excluded Directors) will

be paid an annual retainer.

All directors will be reimbursed for their reasonable out-of-pocket expenses incurred while serving as

Our board of directors has approved the following compensation program

for the non-employee members of our board of directors.

Our non-employee director compensation program is designed to attract and retain qualified individuals to serve on our board of directors.

Our board of directors, on the recommendation of its Compensation Committee, will be responsible for reviewing and approving any changes to the directors’ compensation arrangements.

In consideration for serving on our board of directors, each director (other than Excluded Directors) will be paid an annual retainer.

All directors will be reimbursed for their reasonable out-of-pocket expenses incurred while serving as directors.

The Compensation Committee awards options or restricted stock units for the non-employee members of board of directors.

Cash Compensation.

Under such program, we will pay each non-employee director

a cash fee, payable quarterly, of $4,167 per month for service on our board of directors.

Under such program, we currently pay each non-employee director a cash fee, payable quarterly, of $5,000 per month for service on our board of directors.

Equity Awards.

Each non-employee director will receive

a one-time initial stock option award for 16,216 shares of our common stock, which options shall vest in arrears in two equal

tranches on the first and second anniversaries of service on our Board.

Each non-employee director shall also be eligible to receive

grants of stock options, each in an amount designated by the Compensation Committee of our board of directors, from any equity compensation

plan approved by the Compensation Committee of our Board.

In addition to such compensation, we will reimburse each non-employee director

for all pre-approved expenses within 30 days of receiving satisfactory written documentation setting out the expense actually

incurred by such director.

These include reasonable transportation and lodging costs incurred for attendance at any meeting of our board

of directors.

The following table sets forth the director compensation we accrued

in the year ended December 31, 2023 (excluding compensation to our executive officers set forth in the summary compensation table

Douglas Miscoll

Each non-employee director receive a one-time initial stock option award for 161,290 shares of our common stock, which options shall vest in arrears in equal tranches monthly for one year.

Each non-employee director

shall also be eligible to receive grants of stock options, each in an amount designated by the Compensation Committee of our board of directors, from any equity compensation plan approved by the Compensation Committee.

In addition to such compensation, we reimburse each non-employee director for all pre-approved expenses within 30 days of receiving satisfactory written documentation setting out the expense actually incurred by such director.

These include reasonable transportation and lodging costs incurred for attendance at any meeting of our board of directors.

The following table sets forth the director compensation we accrued in the year ended December 31, 2024 (excluding compensation to our executive officers set forth in the summary compensation table above).

Prateek Gattani $ — $ 3,068,000 $ 3,068,000

Machinist $ — $ — $ —

Jeffrey Jagid $ — $ — $ —

Jeffrey Kurtz $ — $ 450,005 $ 450,005

David Solimine $ — $ 450,005 $ 450,005

David Pfeffer $ 30,000 $ 450,005 $ 480,005

Of the amount reported in the “Fees or Paid in Cash” column, $10,000 was deferred to and paid in 2023.

$ 30,000 $ 4,418,015 $ 4,448,015

Atlantic International’s Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information

Atlantic International does not have any formal policy that requires the Company to grant, or avoid granting, equity-based compensation to its executive officers at certain times.

Consistent with its annual compensation cycle, the Compensation Committee has granted annual equity awards to its directors, and might grant annual equity awards to its executive officers in the future.

The timing of any equity grants to directors or executive officers in connection with new hires or other non-routine grants is tied to the event giving rise to the award (such as an executive officer’s commencement of employment effective date).

As a result, in all cases, the timing of grants of equity awards, including stock options or RSUs, occurs independent of the release of any material nonpublic information, and Atlantic does not time the disclosure of material nonpublic information for the purpose of affecting the value of equity-based compensation.

Additionally and as disclosed above, pursuant to his board of directors agreement with the Company dated April 15, 2024, Mr.

Prateek Gattani, our Chairman of the Board, received 1,300,000 RSUs, as part of his director compensation, which vested upon the date of grant and will expire five years from the date of issue.

Additionally, 161,290 RSUs were granted to each of Jeffrey Kurtz, David Solimine and David Pfeffer upon completion of the Lyneer Merger as director fees that vest equally monthly over one year.

Insider Trading Arrangements and Policies

There are no Rule 10b5-1 trading arrangements held by any officer or director of the Company.

The company has adoped its Insider Trading Policies and Procedures, which is being filed herein as Exhibit 19.1.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth certain information regarding the beneficial

ownership of our common stock as of April 1, 2024 by:

person known by us to be a beneficial owner of more than 5% of our outstanding common stock;

of our directors;

of our named executive officers;

directors and executive officers as a group.

The amounts and percentages of common stock beneficially owned are

reported on the basis of regulations of the SEC governing the determination of beneficial ownership of securities.

Under the rules of

the SEC, a person is deemed to be a “beneficial owner” of a security if that person has or shares “voting power,”

which includes the power to vote or to direct the voting of such security, or “investment power,” which includes the power

to dispose of or to direct the disposition of such security.

A person is also deemed to be a beneficial owner of any securities of which

that person has a right to acquire beneficial ownership within 60 days after April 1, 2024.

Under these rules, more than one person

may be deemed a beneficial owner of the same securities and a person may be deemed a beneficial owner of securities as to which he has

no economic interest.

Except as indicated by footnote, to our knowledge, the persons named in the table below have sole voting and investment

power with respect to all shares of common stock shown as beneficially owned by them.

The applicable percentage ownership is based on 380,648 shares

of common stock outstanding as of April 1, 2024.

Unless otherwise noted below, the address of the persons listed on

the table is c/o SeqLL Inc., 3 Federal Street, Billerica, Massachusetts 01821.

The following table sets forth information regarding beneficial ownership of our outstanding common stock as of March 21, 2025 by (i) each of our directors or executive officers, (ii) all of the persons who serve as our directors and executive officers as a group and (iii) each person who is known by us to be a beneficial owner of more than 5% of our common stock.

Beneficial ownership is determined in accordance with the rules of the SEC and generally requires that such person have voting or investment power with respect to securities.

In computing the number of shares beneficially owned by a person listed below and the percentage ownership of such person, shares underlying options, warrants or convertible securities held by each such person that are exercisable or convertible within 60 days after March 21, 2025 are deemed outstanding, but are not deemed outstanding for computing the percentage ownership of any other person.

Except as otherwise indicated in the footnotes to this table, or as required by applicable community property laws, all persons listed

have sole voting and investment power for all shares shown as beneficially owned by them.

The applicable percentage ownership based on 62,415,686 shares of common stock outstanding as of March 21, 2025.

Name and Address of Beneficial Owner

Shares Percentage

Executive Officers and Directors

Daniel Jones (1)

Frances Scally

Douglas Miscoll (3)

Prateek Gattani 26,723,729 (1)

Machinist (2)

728,814 1.2 %

Jeffrey Jagid (2)

6,521,025 10.4 %

Christopher Broderick (2)

2,581,408 4.1 %

Michael Tenore (2)

1,578,865 2.5 %

Jeff Kurtz (2)

David Solimine (2)

David Pfeffer (4)

All directors and executive officers as a group (8 persons) 38,719,241 62.0 %

5% Stockholders

Laurent Investments, LLC (6)

beneficial ownership of less than 1%.

(i) 59,809 shares of common stock and (ii) 7,272 shares of common stock issuable upon the exercise of currently exercisable

stock options.

(i) 250 shares of common stock and (ii) 1,926 shares of common stock issuable upon the exercise of currently exercisable

stock options.

(i) 1,369 shares of common stock and (ii) 2,711 shares of common stock issuable upon the exercise of currently exercisable

stock options.

(i) 500 shares of common stock and (ii) 1,655 shares of common stock issuable upon the exercise of currently exercisable

stock options.

(i) 406 shares of common stock issuable upon the exercise of currently exercisable stock options and (ii) 18,607 shares

of common stock held by Mr.

Laurent’s spouse, (iii) 38,932 shares of common stock beneficially owned by St.

Laurent Investments LLC, (iv) 14,580 shares of common stock beneficially owned by the Georges C.

Descendants’ Trust and (v) 14,580 shares of common stock beneficially owned by the William C.

St Laurent Descendant’s

5% or Greater Shareholder

IDC Technologies, Inc., 920 Hillview Court, Suite 250, Milpitas, California 95035 25,423,729 (6)

_____________

* Represents ownership of less than one (1%) percent.

(1) As the Chief Executive Officer and sole shareholder of IDC, Mr.

Gattani would have the power to vote and dispose of the shares held by IDC except upon a default as described in note six (6) below.

The address of Mr.

Laurent is 120 NE 136 Avenue, Vancouver, WA 98684.

(i) 38,265 shares of common stock, and (ii) 667 shares of common stock issuable upon the exercise of currently

exercisable warrants.

Laurent is the managing member of St.

Laurent Investments, LLC and, as a result, may be

deemed to have voting and investment power with respect to the shares held by St.

Laurent Investments, LLC.

The address of St.

Investments, LLC is 120 NE 136 Avenue, Vancouver, WA 98684.

address of Wendy St.

Laurent is 120 NE 136 Avenue, Vancouver, WA 98684.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR

INDEPENDENCE.

Gattani is c/o IDC Technologies, Inc.

(IDC), 920 Hillview Court, Suite 250, Milpitas, California 95035.

(2) The address of this person is c/o Atlantic International Corp., 270 Sylvan Avenue, Suite 2230, Englewood Cliffs, New Jersey 07632.

(3) Includes 161,290 RSUs granted upon completion of the Merger as directors fees that vests equally monthly over one year.

(4) The address of Mr.

Pfeffer is c/o SeqLL Inc., 3 Federal Street, Billerica, Massachusetts 01821.

(5) Includes (i) 500 shares of common stock, (ii) 1,030 shares of common stock issuable upon the exercise of currently exercisable stock options and (iii) 161,290 RSUs granted upon completion of the Merger as directors fees that vests equally monthly over one year.

(6) These shares are subject to a pledge agreement entered into with the lender under the Term Note.

If IDC defaults under the Term Note and the lenders under the Term Note are able to foreclose upon IDC’s equity interest in our Company, this would result in a change in control of our Company.

Certain Relationships and Related Transactions and Director Independence

Procedures for Approval of Related Party Transactions

A “related party transaction” is any actual or proposed

transaction, arrangement or relationship or series of similar transactions, arrangements or relationships, including those involving indebtedness

not in the ordinary course of business, to which we or our subsidiaries were or are a party, or in which we or our subsidiaries were or

are a participant, in which the amount involved exceeded or exceeds the lesser of (i) $120,000 or (ii) one percent of the average

of our total assets at year-end for the last two completed fiscal years and in which any related party had or will have a direct

or indirect material interest.

A “related party transaction” is any actual or proposed transaction, arrangement or relationship or series of similar transactions, arrangements or relationships, including those involving indebtedness not in the ordinary course of business, to which we or our subsidiaries were or are a party, or in which we or our subsidiaries were or are a participant, in which the amount involved exceeded or exceeds the lesser of (i) $120,000 or (ii) one percent of the average of our total assets at year-end for the last two completed fiscal years and in which any related party had or will have a direct or indirect material interest.

A “related party” includes:

3 unchanged sentences

• any entity in which any of the foregoing is a partner or principal or in a similar position or in which such person has a 10% or greater beneficial ownership interest.

In March 2021, our board of directors adopted a written related-party transactions

Pursuant to this policy, the Audit Committee of our board of directors will review all material facts of all related-party transactions

and either approve or disapprove entry into the related-party transaction, subject to certain limited exceptions.

In determining

whether to approve or disapprove entry into a related-party transaction, our Audit Committee shall take into account, among other

factors, the following:

(i) whether the related-party transaction is on terms no less favorable to us than terms generally available

from an unaffiliated third party under the same or similar circumstances;

(ii) the extent of the related party’s interest in

the transaction;

In June 2024, our board of directors adopted a written related-party transactions policy.

Pursuant to this policy, the Audit Committee of our board of directors will review all material facts of all related-party transactions and either approve or disapprove entry into the related-party transaction, subject to certain limited exceptions.

In determining whether to approve or disapprove entry into a related-party transaction, our Audit Committee shall take into account, among other factors, the following:

(i) whether the related-party transaction is on terms no less favorable to us than terms generally available from an unaffiliated third party under the same or similar circumstances;

(ii) the extent of the related party’s interest in the transaction;

and (iii) whether the transaction would impair the independence of a non-employee director.

Related Party Transactions

At December 31, 2023, the Company had the following outstanding payables

to affiliated parties for past services:

SeqLL Omics Inc.

Laurent Realty, Inc.

Total related party payables

Laurent Realty, Inc.

assisted the Company by previously providing

corporate accounting support, this entity is affiliated with William C.

Laurent, a former member of the Company’s board of directors.

SeqLL Omics was formed by Daniel Jones, the Chairman

of the Board and Chief Executive Officer of the Company, and certain other Company employees, for the purpose of carrying on the Company’s

pre-Merger business after the Mergers.

SeqLL Omics currently performs research and development services for the Company, in order to facilitate

the Company’s pre-Merger research and development efforts.

The Company incurred $73,764 in relation to the services provided by

SeqLL Omics during the year ended December 31, 2023.

From April 29, 2019 to April 29, 2020, we entered into a series of

non-convertible promissory notes (the “Promissory Notes”) with St.

Laurent Investments LLC amounting to $1,375,000.

The Promissory

Notes, as amended, are accruing interest at 5% per annum.

In June 2022, we entered into an agreement with St.

Laurent Investments LLC

to extend the maturity date of the Promissory Note to July 31, 2024.

From April 29, 2019 to April 29, 2020, 23 issued a series of non-convertible promissory notes (the “Promissory Notes”) to St.

Laurent Investments LLC, an affiliate of William C.

Laurent, a former member of SeqLL’s board of directors, amounting to $1,375,000.

The Promissory Notes had a one-year term with interest accruing at 10% per annum.

In October 2021, 23 entered into an agreement with St.

Laurent Investments LLC to reduce the interest on $1,375,000 principal amount of the Promissory Notes from 10% to 5% per year starting on October 1, 2021.

On May 30, 2024, we entered into an agreement with St.

Laurent Investments LLC to extend the maturity date of the $1,375,000 Promissory Note, to July 31, 2025.

The interest rate from August 1, 2024 through July 31, 2025 shall be 10% per annum.

See Part III, Item 11 — Executive Compensation for the terms and conditions of employment agreements and senior management consulting agreements and options and restricted stock units issued and/or to be issued to Atlantic International’s officers, directors, consultants and senior management.

Principal Accountant Fees and Services

The following table sets forth the fees billed to us for professional

services rendered by Wolf & Co.

for the years ended December 31, 2023 and 2022:

The following table sets forth the fees billed to us for professional services by our independent registered public accounting firm, RBSM LLP for the years ended December 31, 2024 and 2023:

Services 2024 2023

Audit fees $ 395,700 $ 330,000

Audit-related fees 67,500 25,000

Fees — Audit fees consist of fees billed for the audit of our annual financial statements and the review of the interim

consolidated financial statements.

(2) Audit-Related Fees — Audit-related services consist

of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our financial statements

and are not reported under “Audit Fees.”.

Total fees $ 463,200 $ 355,000

(1) Audit fees — Audit fees consist of fees billed for the audit of our annual financial statements and the review of the interim consolidated financial statements.

(2) Audit-related fees — Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our financial statements and are not reported under “Audit fees.”

Pre-Approval Policies and Procedures

The Audit Committee has the authority to appoint or replace our independent

registered public accounting firm (subject, if applicable, to stockholder ratification).

The Audit Committee is also responsible for the

compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between

management and the independent registered public accounting firm regarding financial reporting) for the purpose of preparing or issuing

an audit report or related work.

The independent registered public accounting firm was engaged by, and reports directly to, the Audit

The Audit Committee pre-approves all audit services and permitted non-audit

services (including the fees and terms thereof) to be performed for us by our independent registered public accounting firm, subject to

the de minimis exceptions for non-audit services described in Section 10A(i)(1)(B) of the Exchange Act and Rule 2-01(c)(7)(i)(C) of

Regulation S-X, provided that all such excepted services are subsequently approved prior to the completion of the audit.

complied with the procedures set forth above, and the Audit Committee has otherwise complied with the provisions of its charter.

The Audit Committee has the authority to appoint or replace our independent registered public accounting firm (subject, if applicable, to stockholder ratification).

The Audit Committee is also responsible for the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent registered public accounting firm regarding financial reporting) for the purpose of preparing or issuing an audit report or related work.

The independent registered public accounting firm was engaged by, and reports directly to, the Audit Committee.

The Audit Committee pre-approves all audit services and permitted non-audit services (including the fees and terms thereof) to be performed for us by our independent registered public accounting firm, subject to the de minimis exceptions for non-audit services described in Section 10A(i)(1)(B) of the Exchange Act and Rule 2-01(c)(7)(i)(C) of Regulation S-X, provided that all such excepted services are subsequently approved prior to the completion of the audit.

We have complied with the procedures set forth above, and the Audit Committee has otherwise complied with the provisions of its charter.

Exhibits and Financial Statement Schedules

Incorporation

Agreement and Plan of Reorganization

1 to Agreement and Plan of Reorganization effective as of June 22, 2023

2 to Agreement and Plan of Reorganization effective as of October 5, 2023

3 to Agreement and Plan of Reorganization effective as of October 17, 2023

(a)(1) List of Financial Statements

The following documents are included in this Report under Part II, Item 8 — Financial Statements and Supplementary Data :

• Report of Independent Registered Certified Public Accounting Firm (PCAOB ID 587 )

• Consolidated Statements of Operations

• Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

• Consolidated Statements of Cash Flows

• Notes to the Consolidated Financial Statements

(a)(2) List of Exhibits

Amended and Restated Agreement and Plan of Reorganization dated as of June 4, 2024 (1)

Amendment No.

4 to Agreement and Plan of Reorganization effective as of November 3, 2023

1 to Amended and Restated Agreement and Plan of Reorganization dated as of June 12, 2024 (2)

Certificate of Merger of Atlantic Merger LLC with and into Lyneer Investments LLC (3)

Certificate of Merger of SeqLL Merger LLC with and into Lyneer Investments LLC (3)

Certificate of Amendment of the Third Amended and Restated Certificate of Incorporation of SeqLL Inc.

3.2 A men ded and Restated Certificate o f Incorporation in effect ( 4 )

Description of Sec urities of Atlantic International Corp

4.2 S pecimen common stock certificate ( 6 )

4.3 F orm of outstanding W arrant ( 7 )

4.4 L etter dated September 16, 2024 to the shareholders of record as of September 26, 2023 ( 8 )

4.5 F orm of outstanding Common Stock Purchase Warrant ( 9 )

10.1 A mended and Restated 20 14 Equity Incentive Plan (1 0 )

10.2 A tlantic International Corp.

2023 Equity Incentive Plan (1 1 )

10.3 A sset Purchase Agreement dated as of May 29, 2023 (1 2 )

10.4 C onsulting Agreement between Atlantic International Corp.

and Robert Machinist (3)

10.5 Executive Employment A g reement between A tlantic International Corp.

and Christopher Broderick (3)

10.6 Executive Employment Agreement between Atlantic International Corp.

and Michael Tenore (3)

10.7 Executive Employment Agreement between Atlantic International Corp.

and Jeffrey Jagid (3)

10.8 Executive Employment Agreement between Atlantic International Corp.

and Todd McNulty (3)

10.9 Executive Employment Agreement between Atlantic International Corp.

and James Radvany (3)

10.10 B oard of Direct ors Agreement (Chairman) between Atlantic International Corp.

and Prateek Gatta nio dated as of April 15, 2024 (3)

10.11 A sset Purchase Agreement between SeqLL and SeqLL Omnics, Inc.

10.12 C onvertible Promissory Note dated June 20, 2024 issued by the Issuer to IDC Technologies Inc.

10.13 T enth Amen dment to Loan A g reement and For bearance A greement ( 8 )

10.14 Amendment No.

5 to Agreement and Plan of Reorganization effective as of January 16, 2024

Amended and Restated Certificate of Incorporation

Amended and Restated Bylaws

Description of Securities

Specimen common stock certificate

Warrant Agency Agreement dated as of August 31, 2021 between SeqLL Inc.

and VSTOCK Transfer LLC

Form of Common Stock Purchase Warrant

Amended and Restated 2014 Equity Incentive Plan

License Agreement dated March 15, 2013 between SeqLL, LLC and Helicos Biosciences Corporation

Sub-License Agreement dated March 15, 2013 between SeqLL, LLC and Helicos Biosciences Corporation

Asset Purchase Agreement dated as of May 29, 2023

Investor Rights Agreement dated as of September 30, 2018

Subsidiaries of the Registrant

Consent of Wolf & Company, P.C.

Certification of Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, as Adopted pursuant to Section 302 of The Sarbanes-Oxley Act of 2002

Certification of Principal Financial Officer pursuant to 18 U.S.C.

Section 1350, as Adopted pursuant to Section 302 of The Sarbanes-Oxley Act of 2002

Certification of Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, as Adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

Certification of Principal Financial Officer pursuant to 18 U.S.C.

Section 1350, as Adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

1 to Convertible Promissory Note dated as of September 12, 2024 made by the Issuer to IDC Technologies Inc.

10.15 N inth Amendment to ABL Credit and Forbearance Agreement (1 3 )

I nsider Tradi ng Polici es and Pro cedures

Subsidiaries of Atlantic International Corp

C onsent of RBSM LLP concerning registration statement on Form S-8

C onsent of RBSM LLP con ce rning registration statements on Form S-3

Rule 13a-14(1) Certification of the Chief Executive Officer

Rule 13a-14(1) Certification of the Chief Financial Officer

Certification Pursuant to 18 U.S.C.

Section 1350 by the Chief Executive Officer, as adopted pursuant to Section 9006 of the Sarbanes-Oxley Act of 2002 .

Certification Pursuant to 18 U.S.C.

Section 1350 by the Chief Financial Officer, as adopted pursuant to Section 9006 of the Sarbanes-Oxley Act of 2002 .

C lawback Policy

Inline XBRL Instance Document